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Adult stem cells (SCs) utilize their abilities of self-renewal and differentiation 
to maintain proper homeostasis of their residing tissue. Malfunctioning of tissue SCs 
can result in multiple developmental disorders and cancers. To maintain balance 
between proliferation and quiescence, and faithfully execute fate determination, tissue 
SCs must be tightly regulated. Thus, understanding the molecular mechanisms of 
tissue SCs proliferation/quiescence and how their fate is determined are of critical 
importance in stem cell biology and medicine.  
Hair follicle stem cells reside in the bulge and remain relatively quiescent 
throughout the cycling of the hair follicle. During quiescence, hair follicle stem cells 
choose between the two fates prior to activation – migrate out from their niche and 
become differentiated progenitors or remain in the niche and self-renew. To 
understand how 1) hair follicle stem cells quiescence is maintained and 2) their 
quiescence relates to fate decision, we explored different aspects of regulation.  
In our effort to address the first question, we revealed how a key transcription 
factor of hair follicle stem cell activation and proliferation, Runx1, plays a role in 
regulating multiple Cyclin-Dependent Kinase inhibitors (CDKis). We found that 
multiple CDKis including p15, p21, p27, and p57 are highly expressed during 
quiescence. In the absence of p21, hair follicle stem cells fail to enter quiescence in a 
 timely manner. Moreover, we discovered that Runx1 and p21 interaction plays a 
context-dependent role under different proliferative environments. Finally, we 
discovered a novel function of CDKis in regulating transcription of other CDKis, 
independent of kinase-inhibitory function. Together, we unveil the robust mechanism 
of hair follicle stem cell quiescence by transcriptional regulation of cell cycle 
regulators.  
To address the second question, we took a very different approach. Given the 
importance of histone methylation in regulating embryonic SCs self-renewal and 
differentiation, we asked how such regulation might take part in maintaining hair 
follicle stem cells quiescence and fate determination. We show that a distinct low level 
of different histone methylation marks characterizes quiescent hair follicle stem cells, 
and this level seems to be regulated by growth factor signaling including Bmp. These 
marks are associated with both transcriptional activation (H3K4me3) and repression 
(H3K9me3 and H3K27me3) of chromatin at specific gene promoters. Strikingly, 
globally low status of H3K4me3, H3K9me3, and H3K27me3 during quiescence is 
associated with higher genome plasticity, which likely allows hair follicle stem cells to 
make a fate decision prior to activation. Collectively, our findings suggest that the 
mechanism of maintaining hair follicle stem cells quiescence is robust and adds more 
biological significance to quiescence than previously realized by associating this state 
with plasticity for fate determination.  
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CHAPTER 1 
STEM CELL DYNAMICS DURING TISSUE HOMEOSTASIS 
 
 
 
 
 
 
 
1.1 General notions of stem cells 
Stem cells are functionally defined as cells capable of self-renewal and 
differentiation during an extended period of time (Smith 2001; Weissman, Anderson 
et al. 2001). Multiple stem cell types exist in an organism for proper homeostasis and 
they vary greatly in their innate and residential properties. The ability of stem cells to 
give rise to multiple lineages is termed ‘potency’ (Lanza 2004). Depending on the 
potency, stem cells can be hierarchically characterized as pluripotent, multipotent, 
oligopotent, and unipotent. Embryonic stem cells (ESCs) are derived from the inner 
cell mass of the blastocyst and are pluripotent, being able to give rise to all cell types 
of the organism – endodermal, ectodermal, and mesodermal lineages (Evans and 
Kaufman 1981; Martin 1981; Thomson, Itskovitz-Eldor et al. 1998). ESCs self-renew 
and are maintained in vitro. Many studies have identified critical regulators of ESC 
self-renewal such as Oct4, Sox2, Nanog and Myc. These factors have been recently 
used to reprogram already differentiated cells into pluripotent cells, which are named 
‘induced pluripotent stem cells (iPSCs)’ (Takahashi and Yamanaka 2006). Very 
similar to ESCs, iPSCs carry pluripotency and recent studies in this field are focused 
  2 
on efficient reprogramming as well as safer use of these cell types toward disease 
treatment (Cherry and Daley 2013).  
Another type of stem cells is the tissue stem cells. Tissue stem cells are more 
lineage-restricted (oligopotent or multipotent) and they maintain the native tissue they 
reside in during normal adult homeostasis as well as help repair tissue injury 
(Morrison and Spradling 2008). Tissue stem cells are kept in a specialized 
microenvironment, known as the niche. There the tissue stem cells are provided with 
support and nurtured by the surroundings such as growth factors, vascularization, and 
other signaling molecules. Some tissue stem cells such as hematopoietic and hair 
follicle stem cells remain relatively quiescent within their niche, likely to keep away 
from stem cell exhaustion as well as accumulation of replication-associated genotoxic 
stress such as telomere shortening and DNA mutations (Fuchs 2009). On the other 
hand, other tissue stem cells such as epidermal and intestinal stem cells undergo rapid 
turnover during normal homeostasis suggesting different regulatory mechanisms exist 
in aiding tissue stem cell self-renewal and differentiation (Barker, van Es et al. 2007; 
Clayton, Doupe et al. 2007). 
Stem cells have great potential for clinical applications due to their innate 
capability of being able to live long and give rise to differentiated cell types. 
Moreover, failure of proper functioning of stem cells very often results in multiple 
diseases such as cancer or tissue degeneration (Daley 2012). Thus, it is critical to 
understand the molecular basis and cellular behavior of stem cells for their further use 
in stem cell-based therapies. This chapter reviews various aspects of dynamic behavior 
and regulation of stem cells.  
  3 
1.2 Hair follicle stem cells and adult hair cycle 
Tissue stem cells  possess the ability to maintain their native residing tissues 
intact during homeostasis (Fuchs 2009; Sada and Tumbar 2013). In order to do so, 
tissue stem cells balance between proliferation and quiescence as well as decisions on 
their fates. Different tissue stem cells utilizes different mechanisms such as symmetric 
or asymmetric cell division, as well as cell-extrinsic factors to maintain their stem cell 
pool while giving rise to cells that compose their native tissue (Sada and Tumbar 
2013). Hair follicles undergo cycles of growth and degeneration during the life time of 
a mouse (Blanpain and Fuchs 2006; Lee and Tumbar 2012). Each cycle lasts about 
three weeks and consists of anagen (growth), catagen (regression) and telogen 
(quiescence) (Cotsarelis 2006). First, hair cycle starts around postnatal day (PD) 21 
when hair follicles are at telogen. Prior to activation, some quiescent hair follicle stem 
cells migrate downward from the bulge (niche) to the hair germ without self-renewing, 
where cells become differentiated progenitors (Zhang, Cheong et al. 2009). The hair 
germ is a structure below the bulge that at least transiently contains stem cells. As 
cells of the hair germ start dividing rapidly, hair follicle is considered to be in anagen. 
During anagen, remaining cells of the bulge self-renew by symmetric divisions to 
maintain their pool. In addition, progenitors of the Matrix generate terminally 
differentiated cells that form different lineages of the Inner Root Sheath (IRS), as well 
as the hair shaft (Tumbar 2012). During catagen (~PD36), bulge cells re-enter 
quiescence, and the lower hair follicle structure undergoes apoptosis and regression.  
The mouse hair follicle serves as an excellent model system for studying the 
dynamic behavior of tissue stem cells. First, the cyclic behavior is relatively 
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synchronous across the mouse skin, allowing researchers to isolate large quantities of 
stem cells at desired stages in their adult homeostatic cycle. Second, hair follicle stem 
cells reside in a distinct location (bulge) and their proliferative behavior directly 
correlates with the growth of hair follicles, which can be recognized by hair coat color, 
skin thickness, and histological approaches (Muller-Rover, Handjiski et al. 2001). 
Thirdly, molecular characterization has revealed that hair follicle stem cells possess 
distinct molecular makeup, providing researchers a basis for understanding different 
regulatory axes of hair follicle stem cell dynamics (Tumbar, Guasch et al. 2004). 
Lastly, hair follicle stem cells act as a pool in which a few of them migrate out from 
the niche while they are still quiescent, and are destined to become progenitors that 
form the mature hair follicle (Zhang, Cheong et al. 2009). Only later the stem cells 
remaining in the niche undergo self-renewal to maintain their stem cell pool. This 
provides a temporal separation of two important mechanisms – proliferation (anagen) 
and fate choice (catagen-telogen) – allowing us to dissect both aspects using hair 
follicle stem cells. Importantly, many of the findings made from using hair follicle as a 
model can be applied to other tissue stem cell systems as well.  
Classically, before bulge cells were shown to contain hair follicle stem cells, 
bulge cells were denoted as label-retaining cells (LRCs) due to their infrequently 
dividing property. The initial labeling with 3[H]-thymidine or 5-Bromo-deoxyuridine 
(BrdU), nucleotide analogs that get incorporated in the DNA during S phase, was 
retained over time (Cotsarelis, Sun et al. 1990; Taylor, Lehrer et al. 2000; Oshima, 
Rochat et al. 2001). From the observation that these bulge LRCs contribute to other 
regions of hair follicles, subsequent studies revealed that the bulge LRCs carry 
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multipotent stem cells. Single cells isolated from the bulge were able to be cultured in 
vitro for a prolonged time, and were still able to contribute to all lineages of hair 
follicle after two consecutive transplantations (Claudinot, Nicolas et al. 2005) as well 
as long-term lineage tracings (Zhang, Cheong et al. 2009).  
Recently, more precise mapping of hair follicle stem cells proliferation 
dynamics was done using the tetracycline-inducible (tet-off) system (Tumbar, Guasch 
et al. 2004; Zhang, Cheong et al. 2009; Zhang, White et al. 2010). When doxycycline 
is introduced to mouse diet, H2B-GFP mRNA expression is shut off and upon 
division, the H2B-GFP protein is equally diluted in half in between daughter cells 
(Waghmare, Bansal et al. 2008). These studies revealed that the bulge cells on average 
divide three times during one hair cycle. Chapter 2 contains a concise review of 
dynamic regulatory mechanisms such as signaling molecules, growth factors, key 
transcription factors, and hair follicle surrounding environments that play critical roles 
in hair follicle stem cells self-renewal and differentiation (Lee and Tumbar 2012). 
 
 
1.3 Cell cycle regulation of stem cells 
Progression through the cell-cycle depends on levels of Cyclin/CDK (Cyclin-
Dependent Kinase). For instance, level of Cyclin D/CDK4 and Cyclin D/CDK6 
complexes peak at G1 to S transition which allow further progression into DNA 
replication. The activities of CDKs are blocked by CDK-inhibitors (CDKis). CDKis 
consists of two families – a Cip/Kip family (p21, p27, and p57) and an Ink4 family 
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(p15, p16, p18, and p19) (Besson, Dowdy et al. 2008). The Ink4 family of the CDKis 
inhibit CDK4 and CDK6 during G1 to S transition, which results in cell-cycle 
dependent behavior. On the other hand, Cip/Kip family of CDKis show broader 
spectrum of inhibition throughout the cell cycle (Tesio and Trumpp 2011).  
Although it has been recently proposed that some tissue stem cells may 
actively cycle throughout life (Li and Clevers 2010), it is generally believed that tight 
regulation of quiescence is fundamental in maintaining tissue stem cells and in 
preventing cancer (Orford and Scadden 2008; Fuchs 2009). Cyclin-Dependent Kinase 
inhibitors (CDKis) play specific roles in regulating cell division in different tissue cell 
types. The Cip/Kip family (p21, p27, and p57) and the Ink4 family (p15, p16, p18, and 
p19) of CDKis have been studied in the hematopoietic stem cell system, where they 
may maintain quiescence and prevent stem cell exhaustion (Matsumoto, Takeishi et al. 
2011; Tesio and Trumpp 2011; Zou, Yoshihara et al. 2011). However, cell cycle 
regulation in other tissue stem cells, such as those of skin and hair follicle, is 
understudied.  
Signaling pathways converge onto transcription factors that may ultimately 
interact with CDKis and control their mRNA expression. However, molecular 
interactions controlling quiescence in tissue stem cells, and how they differ in normal 
homeostasis when compared to a context in which the niche influence on stem cells 
has been perturbed is poorly understood.   
An interesting case of stem cell cell-cycle control is that of p21 (Cdkn1a), 
which seems to inhibit stem cell proliferation in cell culture or transplantation in three 
tissue types - skin (Topley, Okuyama et al. 1999), blood (Cheng, Rodrigues et al. 2000; 
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Viale, De Franco et al. 2009) and brain (Kippin, Martens et al. 2005). However, 
controversial findings show that p21 may have limited roles in normal blood stem cell 
homeostasis (van Os, Kamminga et al. 2007; Foudi, Hochedlinger et al. 2009; 
Matsumoto, Takeishi et al. 2011; Zou, Yoshihara et al. 2011) and instead only act in 
injury conditions.  
In skin and hair follicle, the role of p21 in normal homeostasis has not been 
addressed extensively yet. In addition, we previously found that p21 and the 
transcription factor Runx1, a Runt family member of cancer genes (Speck and 
Gilliland 2002) and a regulator of hair follicle stem cell proliferation (Osorio, Lee et al. 
2008), interact genetically in cultured hair follicle stem cells (Hoi, Lee et al. 2010) but 
the significance of this interaction in the normal tissue also remains unclear.  
p21 knockout mice display no observable defects. However, absence of p21 
led to an increased short-term proliferation potential of in vitro epithelial-derived skin 
keratinocytes as well as increased susceptibility to skin carcinoma formation by 
chemical induction in vivo (Topley, Okuyama et al. 1999). p21, initially identified as a 
transcriptional target of the tumor suppressor p53, plays a role in various cellular 
processes including stem cell aging and maintenance of stem cell quiescence 
(Weinberg and Denning 2002; Ju, Choudhury et al. 2007; Boyer and Cheng 2008). 
This is accomplished by its ability to block S-phase progression by binding to 
proliferating cell nuclear antigen (PCNA), a subunit required for proper DNA 
replication. In addition to its role during normal homeostasis, p21 level is elevated 
upon DNA damage in response to p53 up-regulation, resulting in cell cycle arrest or 
apoptosis (Weinberg and Denning 2002). The level and localization of p21 is 
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important in making a choice between cell death and cell cycle arrest. An apoptotic 
executer, caspase-3 uses p21 as its substrate and cleaves the C-terminal residues 
including the nuclear localization signal and PCNA-interacting domain, compromising 
its activity and localization (Suzuki, Tsutomi et al. 1998; Zhou, Liao et al. 2001). Loss 
of p21 can result in apoptotic cells at areas of neovascularization (Bruhl, Heeschen et 
al. 2004).  
Recently, in addition to their roles in cell cycle regulation, some CDKis (p21 
and p27) have also been shown to play cell cycle-independent roles and can function 
as transcriptional regulators of other genes in conjunction with transcription factors 
such as E2F (Devgan, Mammucari et al. 2005; Pippa, Espinosa et al. 2011; Ferrandiz, 
Caraballo et al. 2012). In Chapter 3, we show how Runx1 transcriptionally regulates 
multiple CDKis mRNA expression in hair follicle stem cells. Moreover, we address 
the role of one CDKi (p21) in regulating timely exit from the cell cycle. In addition, 
the significance and context-dependent role of Runx1-p21 interaction is analyzed. 
Finally, we show a novel mechanism of transcriptional regulation of one CDKi (p15) 
by another CDKi (p21) (Lee, Hoi et al. 2013).     
 
 
1.4 Histone modifications and their regulation of stem cell function 
Chromatin is a complex genetic material of DNA packaged with histones and 
non-histone proteins that form the chromosome (Luger, Mader et al. 1997; Luger, 
Dechassa et al. 2012). The basic organizational unit of chromatin is the nucleosome, 
which consists of 4 core histones (H2A, H2B, H3, and H4) wrapped around ~147bp of 
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DNA, known as “10nm-fiber” or “beads-on-a-string” as visualed by electron-
microscopy (Luger, Mader et al. 1997). Chromatin further compacts into higher order 
domains, forming transcriptionally active “euchromatin” or silent “heterochromatin” 
(Hansen 2002; Horn and Peterson 2002; Giadrossi, Dvorkina et al. 2007).  
Different transcriptional status is driven not only by transcription factors but 
also by multiple factors such as DNA methylation, histone variants, chromatin 
remodeling factors, histone N-terminal modifications etc (Jenuwein and Allis 2001; 
Giadrossi, Dvorkina et al. 2007). Chromatin modifications are relatively well 
established among these factors (Jenuwein and Allis 2001; Kouzarides 2007). For 
instance, H3K4me3 (histone 3 lysine 4 tri-methylation) is associated with active 
genes, while H3K27me3 and H3K9me3 are associated with silenced genes (Bernstein, 
Mikkelsen et al. 2006). These modifications are placed and maintained by specific 
histone modifying enzymes. Suv39h1/h2 (Kmt1a/1b) containing SET (enzymatic 
functional domain of methyl-transferase activity) domain selectively methylates K9 
position (Rea, Eisenhaber et al. 2000; Lehnertz, Ueda et al. 2003). On the other hand, 
histone demethylases such as Jmjd2a (Kdm4a), Jmjd1a (Kdm3a), and Jmjd2c 
(Kdm4c) can remove methyl- residues on same position (Marmorstein and Trievel 
2009). H3K27me3 is placed on and maintained by Ezh2 (Kmt6), an enzymatic 
component of Polycomb Repressive Complexes and can be removed by demethylases 
such as Jmjd3 (Kdm6b), and Utx (Kdm6a) (Shen, Kim et al. 2009; Margueron and 
Reinberg 2011; Orkin and Hochedlinger 2011). Set1a/1b as well as MLL1-4 are 
homologs of Drosophila Trithorax group complexes and function in placing and 
maintaining H3K4me3 mark on active genes, while another set of demethylases act 
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specifically to remove this mark (Roguev, Schaff et al. 2001; Miller, Krogan et al. 
2001; Milne, Briggs et al. 2002; Iwase, Lan et al. 2007) . Recent studies revealed that 
some developmental genes are poised in their expressions via presence of both active 
(H3K4me3) and repressive (H3K27me3) marks termed ‘bivalency’, which is resolved 
upon lineage restriction (Bernstein, Mikkelsen et al. 2006; Sparmann and van 
Lohuizen 2006; Mikkelsen, Ku et al. 2007).  
Together with genetic studies of histone modifying enzymes and next-
generation sequencing technology, histone modification maps and their regulatory 
networks in different cell types including stem cells, lineage-restricted cells, and 
cancer cells have revealed the great importance of epigenetic regulations in stem cell 
biology. The chromatin of embryonic stem cells is more open and hyperdynamic, and 
differentiation reduces the chromatin dynamics (Meshorer, Yellajoshula et al. 2006). 
In addition, embryonic stem cells global chromatin composition is distinct from that of 
differentiated cell types (Hawkins, Hon et al. 2010). Moreover, core pluripotency 
factors such as Oct4, Sox2, Klf4 and Myc (Takahashi and Yamanaka 2006) that are 
critical for reprogramming as well as other factors such as Nanog, interact with 
multiple chromatin factors including remodelers and histone modifying enzymes that 
lead to global changes to the gene expression, which determines cell fate (Orkin and 
Hochedlinger 2011). Interestingly, recent studies revealed that histone modifying 
enzymes act as important factors in mediating efficient reprogramming (Onder, Kara 
et al. 2012) by transcription factors and that H3K9 methylation hinders the 
reprogramming process (Chen, Liu et al. 2013).  
  11 
Specific manipulations of Polycomb group proteins as well as different histone 
modifying enzymes have revealed that tissue stem cells also employ multiple 
mechanisms of chromatin regulation by histone methylation in not only maintaining 
the stem cell pool, but also in proper differentiation, tissue homeostasis and cancer 
(Park, Qian et al. 2003; Iwama, Oguro et al. 2004; Molofsky, Slutsky et al. 2006; 
Fasano, Dimos et al. 2007; Sangiorgi and Capecchi 2008; Sen, Webster et al. 2008; 
Ezhkova, Pasolli et al. 2009; Ezhkova, Lien et al. 2011; Margueron and Reinberg 
2011; Chen, Skutt-Kakaria et al. 2012; Ye, Fan et al. 2012; Pal, Bouras et al. 2013). 
However, the consequences of perturbing these modifications are shockingly mild, 
most likely due to compensation or potential redundancy among multiple histone 
marks, which we are just beginning to understand. Recent studies suggest that Ezh2-
mediated changes in H3K27me3 govern the rates and timing of cell differentiation in 
the mammary epithelium (Pal, Bouras et al. 2013). In addition, Ezh2 fine tunes the 
timing of developmental switches and the balance between self-renewal and 
differentiation of multiple stem/progenitors including, skeletal (Juan, Derfoul et al. 
2011), hematopoietic (Su, Basavaraj et al. 2003; Mochizuki-Kashio, Mishima et al. 
2011), neural (Pereira, Sansom et al. 2010). Moreover, another subunit of Polycomb 
Repressive Complex, Bmi1, also plays critical role in similar processes (Park, Qian et 
al. 2003; Iwama, Oguro et al. 2004; Fasano, Dimos et al. 2007; Sangiorgi and 
Capecchi 2008).  
Some histone demethylases (Kdm4b and Kdm6b) are regulated by BMP 
signaling, which is critical for osteogenic differentiation of mesenchymal stem cells 
(Ye, Fan et al. 2012). Importantly, mis-regulation of factors implicated in histone 
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methylation is commonly found in cancers, suggesting that balancing the levels of 
these class of epigenetic regulators is essential not only for normal homeostasis but 
also for preventing cancer (Sauvageau and Sauvageau 2010).  
Proliferation associated changes in chromatin organization were also observed 
not only in tissue stem cells but also in more lineage-committed cells. For instance, 
histone hypomethylation was a distinct characteristic of quiescent B lymphocytes, 
which was restored upon proliferation onset (Baxter, Sauer et al. 2004). In addition, 
these quiescent B lymphocytes were more efficiently reprogrammed upon somatic 
nuclear transfer suggesting a higher plasticity associated with quiescence (Baxter, 
Sauer et al. 2004).  
In skin, Ezh2-deficient basal layer cells of the epidermis undergo precocious 
epidermal differentiation during skin development (Ezhkova, Pasolli et al. 2009; 
Ezhkova, Lien et al. 2011). Ezh2 is enriched in basal layer cells and its loss results in 
decreased proliferation of epidermal keratinocytes in vivo as well as in vitro. 
Repression through H3K27me3 on differentiation-specific genes is relieved upon 
Ezh2 loss and results in precocious expression of late-differentiation genes and 
acquisition of skin barrier function. Postnatal loss of Ezh2 is compensated by Ezh1, 
and loss of both appears to impair proliferation of hair follicle progenitor matrix cells 
and lack of differentiated lineages during hair morphogenesis (Ezhkova, Lien et al. 
2011). Moreover, recently it has been shown that complete lack of H3K27me3 via 
double knockout of both Ezh1 and Ezh2 in epidermis progenitors results in loss of a 
specific lineage specialized in mechano-sensing of fine touch (Ezhkova, Lien et al. 
2011; Bardot, Valdes et al. 2013). This was in fact the first and only example to date 
  13 
in which H3K27me3 proved indispensable for specification of a differentiated lineage, 
but also skin is the only tissue where both enzymes have been knocked out 
simultaneously. Although work in embryonic SCs predicted a more widespread role of 
the H3K27me3 mark in tissue development, since Ezh1 and Ezh2 act redundantly, it 
remains to be seen if knocking them out together in other tissues besides skin will 
broaden our understanding of their function in lineage specifications.  
Absence of Jmjd3, an H3K27me3-demethylase, blocks differentiation of 
organotypic human epidermal cells while its over-expression induces differentiation 
(Sen, Webster et al. 2008). However, if and how adult hair follicle stem cells employ 
histone modifications as means of regulation to achieve proper hair follicle 
homeostasis require further exploration.  
In Chapter 4, we show preliminary results of regulation of histone H3 tri-
methylations at K9, K27, and K4 that takes place during hair follicle homeostasis. We 
show that hair follicle stem cells have a distinct landscape of these histone 
modifications in their genome that undergoes global changes upon self-renewal and 
differentiation processes. These changes seem to be driven by transcriptional 
regulation of multiple histone modifying enzymes triggered by one or more growth 
factor signaling. Finally, the global status of quiescent hair follicle stem cells seems to 
place the chromatin in a more hyperdynamic state as suggested by histone H2B-GFP 
exchange rates. Taken together, our data suggest a model in which the state of hair 
follicle stem cells in quiescence is associated with low levels of both repressive and 
activating histone marks and more hyper-dynamic chromatin which may reflect low 
epigenomic identity and higher genome plasticity. This state may be important for the 
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fate choice between self-renewal and differentiation that takes place in quiescence for 
hair follicle and potentially for other tissue stem cells. It will remain to be shown 
whether this epigenetic state is crucial for fate decisions, and whether other epigenetic 
marks including other histone modifications may follow the same patterns as the ones 
we describe here.  
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CHAPTER 2 
HAIRY TALE OF SIGNALING IN HAIR FOLLICLE DEVELOPMENT 
AND CYCLING 
1
 
 
 
 
 
 
2.1 Summary 
Hair follicle (HF) is an appendage from the vertebrate skin epithelium, and is 
critical for environmental sensing, animal appearance, and body heat maintenance. 
HFs arise from the embryonic ectoderm and regenerate cyclically during adult life. 
Distinct morphological and functional stages from development through homeostasis 
have been extensively studied for the past decades to dissect the critical molecular 
mechanisms. Accumulating work suggests that different signaling cascades, such as 
Wnt, Bmp, Shh, and Notch, together with specific combinations of transcription 
factors are at work at different stages. Here we provide a comprehensive review of 
mouse genetics studies, which include lineage tracing along with knockout and over-
expression of core genes from key signaling pathways, to paint an updated view of the 
molecular regulatory network that govern each stage of hair follicle development and 
adult cycling. 
 
2.2 Introduction to general notions of cell and tissue signaling 
                                                 
1
 This chapter has been published: Lee, J. and Tumbar, T (2012). “Hairy tale of signaling in hair follicle 
development and cycling.” Semin Cell Dev Biol 23(08): 906-916.  
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Proper tissue architecture and function depends upon each cell in the body 
faithfully fulfilling the purpose of its existence. The harmony among complex 
signaling networks within and between cells must be strictly maintained in order to 
prevent developmental defects and fatal diseases. Skin homeostasis is essential for 
survival, and protects the organism against various environmental assaults such as UV 
irradiation, microbes, harmful chemicals, etc. (Blanpain and Fuchs 2006). Mammalian 
skin epithelium carries hair follicle (HF) appendages important for overall skin 
homeostasis, sensory purposes, maintaining body temperature, and establishing proper 
appearance. Moreover, HF is an ideal mammalian model system to understand more 
general principles of intra- and inter-cell signaling pathway communication that may 
apply to other tissues. HF possesses distinct characteristics that allow in depth 
dissection of molecular signaling. First, synchronous, distinct and dramatic 
morphological changes allow researchers to easily identify well-characterized HF 
stages of development or homeostasis (Muller-Rover, Handjiski et al. 2001; Blanpain 
and Fuchs 2006). Secondly, hair follicle stem cells (HFSCs) of the bulge, which give 
rise to all HF lineages and maintain homeostasis, are well characterized (Cotsarelis, 
Sun et al. 1990; Hsu and Fuchs 2012). HFSCs dynamic behavior of self-renewal, 
differentiation, and quiescence, is essential for the HF proliferative and growth cycle 
(Cotsarelis 2006; Zhang, Cheong et al. 2009). Lastly, stem, progenitor, and terminally 
differentiated cells display specific HF location and molecular marker expression (Hsu 
and Fuchs 2012), which allows their identification, targeting and isolation for deeper 
exploration. 
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The signals that govern skin and HF cell proliferation and differentiation 
during development and homeostasis have been intensively explored in the past 
decades (Table 2.1) (Plikus 2012). Several transcription factors such as Runx1 (Osorio, 
Lee et al. 2008; Hoi, Lee et al. 2010), Tcf3/4 (Nguyen, Merrill et al. 2009), NFATc1 
(Horsley, Aliprantis et al. 2008), Lhx2 (Rhee, Polak et al. 2006), Sox9 (Vidal, 
Chaboissier et al. 2005), Tbx1 (Chen, Heller et al. 2012), p63 (Mills, Zheng et al. 1999; 
Yang, Schweitzer et al. 1999), Dlx3 (Hwang, Mehrani et al. 2008), Lef1 
(Vangenderen, Okamura et al. 1994), Msx2/Foxn1 (Cai, Lee et al. 2009), Gli 
(Grachtchouk, Mo et al. 2000; Mill, Mo et al. 2003), Gata3 (Kaufman, Zhou et al. 
2003), and etc., play critical roles in HFSC activation, self-renewal, differentiation, 
and cycling by modulating several key signaling pathways, which include Wnt, Bmp, 
Shh, and Notch. We begin by underlying basic molecular principles for each pathway, 
and next we review how different combinations of these pathways regulate HF 
development and cycling. 
 
2.2.1 Wnt signaling  
Wnt molecules act as secreted, morphogenetic signals, which bind to Frizzled 
or LRPs receptors (Gumbiner 1997; Alonso and Fuchs 2003; Logan and Nusse 2004). 
When Wnt is absent, Axin/GSK-3β /APC kinase complex phosphorylates 
serine/threonine residues of cytoplasmic β-catenin, leading to ubiquitin-mediated 
degradation. Upon Wnt ligand-binding to receptors, Dishevelled binds to the intra-
cellular domains of the receptors, sequestering and allowing LRP-mediated 
phosphorylation of Axin/GSK-3β/APC complex, which inhibits phosphorylation and  
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Table 2.1. Categorized genetic studies of key components of signaling pathway and 
transcription factors in hair follicles.  
Signals Mutation type Hair follicle phenotype Reference  
1. Wnt-related     
Wnt3 K14-Wnt3 Reduced hair follicle length, 
premature catagen onset 
Millar (1999)  
Wnt7a K14-Wnt7a Increased hair follicle 
neogenesis upon wounding 
Ito (2007)  
Dvl2 K14-Dvl2 Reduced hair follicle length, 
premature catagen onset 
Millar (1999)  
Dkk1 K14-Dkk1 Lack of placode formation Andl (2002)  
 K5rtTA; TRE-Dkk1 Lack of hair follicle 
neogenesis upon wounding 
Ito (2007)  
APC K14-Cre; APC fl/fl Aberrent hair follicle growth, 
short, curly whiskers 
Kuraguchi 
(2006) 
 
Lef1 (Transcription 
factor) 
Lef1 -/- Lack of body hair and whisker 
follicles 
van Genderen 
(1994) 
 
 K14-Lef1 Clustered hair follicles, 
irregularly angled shafts 
Zhou (1995)   
 K14-ΔNLef1 Suppressed hair follicle 
differentiation , enhanced 
sebocyte differentiation 
Merrill (2001)  
 K14-ΔNLef1 Progressive hair loss and cyst 
and tumor formation 
Niemann 
(2002) 
 
β-catenin K14-ΔNβ-catenin (constitutively 
active) 
De novo hair follicle induction Gat (1998)  
 K14-Cre; β-catenin fl/fl Lack of placode formation, 
loss of hair in the first hair 
cycle 
Huelsken 
(2001) 
 
 K5-S33Yβ-cateninER Anagen induction and 
enhanced hair follicle 
proliferation 
Van Mater 
(2003) 
 
 K14-ΔNβ-cateninER Anagen induction and de novo 
hair follicle formation  
Lo Celso 
(2004) 
 
 K14-ΔNβ-catenin (hemizygous) Precocious bulge stem cell 
activation 
Lowry (2005)  
 K14-CreERtm; β-catenin fl/fl Loss of bulge stem cell 
quiescence and maintenance 
Lowry (2005)  
 K14-CreERtm; β-catenin fl/fl Lack of hair follicle 
neogenesis upon wounding 
Ito (2007)  
 K14-Cre; Ctnnb1 (ex3)fl/+ (Dominant 
active) 
Premature hair follicle placode 
development, predominant 
differentiation towards hair 
shaft, defects in hair follcle 
development 
Zhang (2008)  
 Cor-Cre (DP specific); Ctnnb1 fl/fl Reduced hair follicle length 
and thinning  
Enshell-
Seijffers 
(2010) 
 
 K15-ΔNβ-cateninER Increased bulge proliferation 
and expansion 
Baker (2010)  
 ΔK5ΔNβ-cateninER Ectopic hair follicle induction 
In sebaceous gland 
Baker (2010)  
Tcf3/4 
(Transcription 
factor) 
K14-ΔNTcf3 Suppressed epidermal 
differentiation 
Merrill (2001)  
  K14rtTA; TRE-mycTcf3 Lack of epidermal 
differentiation and sebaceous 
gland 
Nguyen 
(2006) 
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Table 2.1. (continued) 
 
2. BMP/TGFβ-
related 
    
TGFβ1 TGFβ1 -/- Advanced hair follicle 
formation, delayed catagen 
development 
Foitzik (1999), 
Foitzik (2000) 
 
TGFβ2 TGFβ2 -/- Delay of hair follicle 
morphogenesis and reduced 
number of hair follicles 
Foitzik (1999)  
TGFβ3 TGFβ3 -/- No effect Foitzik (1999)  
TGFβRII K14-Cre; TβRII fl/fl Prolonged telogen length Oshimori 
(2011) 
 
Bmpr1a K14-Cre; Bmpr1a fl/fl Impaired IRS and hair shaft 
differentiation 
Kobielak 
(2003) 
 
 K14-CreERT2; Bmpr1a fl/fl Impaired postnatal hair follicle 
differentiation 
Andl (2004)  
 En1-Cre; Bmpr1a fl/fl Lack of hair outgrowth, 
defects in Matrix cell 
proliferation and 
differentiation in 
morphogenesis and hair cycle 
Ming Kwan 
(2004) 
 
 Emx1-Cre; Bmpr1a fl/fl Impaired IRS differentiation, 
reduced number of hair follicle 
Yuhki (2004)  
 K14-CreER; Bmpr1a fl/fl Loss of quiescent stem cells Kobielak 
(2007) 
 
Noggin Noggin -/- Reduction of induced hair 
placodes 
Botchkarev 
(1999) 
 
 Msx2-Noggin Impaired hair shaft 
differentiation 
Kulessa 
(2000) 
 
 K14-Noggin Reduction of telogen length, 
increased hair density 
Plikus (2004), 
Plikus (2008) 
 
Activin actβA -/-, actβB -/- Lack of whisker follicles Matzuk (1995)  
Follistatin fs -/- Mis-oriented hair follicles Matzuk (1995)  
 
3. Shh-related     
Shh Shh -/- Arrest in hair follicle 
morphogenesis after placode 
formation 
St-Jacques 
(1998), 
Chiang (1999) 
 
 K14-Shh Normal hair placode formation 
following massive down-
growth and tumor formation 
Oro (1997)  
 hK14-Shh Epidermal hyperplasia / loss of 
epidermal tissue renewal 
Adolphe 
(2004) 
 
Dhh hK14-Dhh Epidermal hyperplasia / loss of 
epidermal tissue renewal 
Adolphe 
(2004) 
 
     
Smo K5-SmoM2 Epidermal hyperplasia, but no 
effect in hair follicle 
development 
Xie (1998)  
 ΔK5-M2SMO Patchy hair loss and 
progressive alopecia 
Grachtchouk 
(2003) 
 
 K14-CreER; RosaSmoM2 / Shh-
CreER;RosaSmoM2 / K15-CrePR; 
RosaSmoM2 
BCC originates not from hair 
follicle bulge but from 
interfollicular epidermis and 
the infundibulum 
Youssef 
(2010) 
 
Gli1,/2/3 
(Transcription 
factor) 
K14-Gli1 Postnatal hair loss and ulcer 
development 
Oro & Higgins 
(2003) 
 
 K5-Gli2 BCC-like tumor formation Grachtchouk 
(2000) 
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Table 2.1. (continued) 
 
 Gli2-/- Arrest in hair follicle 
development 
Mill (2003)  
 K5tTA; TRE-Gli2 BCC-like tumors arising from 
hair follicles  
Hutchin 
(2005) 
 
Ptch1 Ptch1KO1/+ or Ptch1D11/+ Anagen dependent tumor 
formation 
Oro & Higgins 
(2003) 
 
 
4. Notch-related     
Notch MHKA1-NotchΔE (active form) Abnormal differentiation of 
the medulla and the cuticle 
Lin (2000)  
 K5-CreERT; Notch1 fl/fl Epidermal hyperplasia and 
spontaneous skin tumors 
Nicolas (2003)  
 Msx2-Cre; Notch1 fl/fl/ Notch2 fl/fl/ 
Notch3 fl/fl 
Failure to maintain IRS cells, 
hair follicle cell conversion to 
epidermal cysts  
Pan (2004)  
 Ivl-Notch-IC Delay in IRS differentiation 
followed by alopecia 
Uyttendaele 
(2004) 
 
 K15-CrePR1; Notch1 fl/fl/ Notch2 
fl/fl/ Notch3 -/- 
Bulge stem cell fate 
converstion to interfollicular 
epidermis and formation of 
epidermal cysts 
Demehri 
(2009) 
 
RBPj Nestin-Cre; RBP-J fl/fl Hair loss, cyst formation, and 
epidermal hyperkeratinization 
Yamamoto 
(2003) 
 
 K14-Cre; RBP-J fl/fl Absense of spinous layer, 
impaired matrix cell 
differentiation to IRS and hair 
shaft 
Blanpain 
(2006) 
 
 K15-CrePR1; Rbpj fl/fl Bulge stem cell fate 
conversion to interfollicular 
epidermis and formation of 
epidermal cysts 
Demehri 
(2009) 
 
 K15-CrePR1; Rbpj fl/fl / K5-Cre; 
Rbpj fl/fl 
Impaired hair follicle 
differentiation with 
mesenchymal RBP-jκ deletion 
Hu (2010)  
 Tgfb3-Cre; Rbpj fl/fl Impaired epidermal 
differentiation 
Lin (2011)  
γ-Secretase Msx2-Cre; PS1 fl/fl  / Msx2-Cre; 
PS2 fl/fl 
Failure to maintain IRS cells, 
hair follicle cell conversion to 
epidermal cysts  
Pan (2004)  
Jagged1 K5-Cre; Jag1 fl/fl / K14-CreER; 
Jag1 fl/fl / K14ΔNβ-cateninER; Jag1 
fl/fl 
Inhibition of the hair growth 
cycle and cyst formation 
Estrach (2006)  
O-fucosyltransferase 
1 
Tgfb3-Cre; Pofut1 fl/fl Disrupted telogen hair follicle, 
delay in anagen activation 
Lin (2011)  
 
5. EGF/FGF-
related 
    
TGFα Tgfα -/- Misoriented, misaligned hair 
follicles  
Luetteke 
(1993), Mann 
(1993) 
 
FGF7 K14-Fgf7 Lack of hair follicle formation Guo (1993)  
FGF5 Fgf5 -/- Elongated hair follicle Herbert (1994)  
 K5-HERCD-533 (dominant 
negative) 
Short and waved hair follicles 
and curly whiskers followed 
by gradual alopecia 
Murillas 
(1995) 
 
Fgfr2 Fgfr2-IIIb-/- Abnormal hair medullar 
differentiation 
Petiot (2003)  
FGF10 Fgf10 -/- Reduced hair follicle number 
and abnormal bulb expansion 
with lack of differerentiated 
hair shaft 
Ohuchi (2000)  
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Table 2.1. (continued) 
 
FGF18 K5-Cre; Fgf18 fl/fl Shortened telogen length Kimura-Ueki 
(2012) 
 
 
6. Transcription 
factors  
Mutation type Hair follicle phenotype Reference Related 
signals 
Runx1 K14-Cre; Runx1 fl/fl / β-
actinCreER; Runx1 fl/fl / Runx1 
fl/Runx1-CreER 
Epithelium: Delayed hair 
follicle morphogenesis and 
anagen entry, reduced 
proliferation; mesenchyme 
(predominant): abnormal hair 
follicle morphogenesis and 
enhanced SG formation 
Osorio (2008), 
Hoi (2010), 
Osorio (2011)  
De-regulates 
Wnt 
signaling 
Sox9 Y10-Cre; Sox9 fl/fl Lack of external hair, 
proliferation defects, ORS 
cells fate change to epidermal 
Vidal (2005) Downstream 
of Shh 
signaling 
Lhx2 K14-Lhx2 (Tg) or Lhx2 -/- (KO) Tg; Suppression of hair 
follicle differentiation; KO: 
Reduction of hair follicle 
density but no efffect on 
differentiation 
Rhee (2006) De-regulates 
Wnt and Shh 
downstream 
factors 
NFATc1 Nfatc1 -/- and K14-Cre; Nfatc1 fl/fl Normal hair follicle 
morphogenesis, premature 
stem cell activation and hair 
follicle growth 
Horsley 
(2008) 
Downstrem 
of Bmp 
signaling 
Tbx1 K14-Cre; Tbx1 fl/fl Delayed hair cycle entry upon 
shaving, loss of stem cells 
upon repeated depilation, 
reduced proliferative potential 
Chen (2012) Regulates 
Bmp 
signaling 
Dlx3 K14-Cre; Dlx3 fl/fl Alopecia due to failure of hair 
shaft and IRS differentiation 
Hwang (2008) Downstream 
of Wnt 
signaling 
Msx2 / Foxn1 Msx2 -/- ; Foxn1 -/- Impaired IRS and medulla 
differentiation 
Cai (2009) De-regulates 
Notch 
signaling 
p63 p63 -/- or K5tTA; TRE-ΔNp63α Lack of placode formation, 
defect in hair follicle stem 
cells and hair cycling 
Mills (1999), 
Yang (1999), 
Romano 
(2010) 
De-regulates 
Wnt 
signaling 
Gata3 Gata3 -/- Failure in the IRS precursors 
differentiation 
Kaufman 
(2003) 
Regulates 
Wnt 
signaling 
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ubiquitin-mediated degradation of β-catenin (Clevers and Nusse 2012). Excess of 
cytoplasmic un-phosphorylated β-catenin molecules translocate into the nucleus, 
where they interact with Lef/Tcf transcription factors (Vangenderen, Okamura et al. 
1994). Wnt transcriptional targets include the Wnt molecules themselves, Eda, Fgfs, 
Keratins, Lef1, Movo1, Foxn1, Msx2, Follistatin, Tgfβ2, Cyclin D1 and other cell 
cycle related genes (Clevers and Nusse 2012). Dkk1 is an inhibitor of LRP (Andl, 
Reddy et al. 2002). β-Catenin also interacts with cadherins (E-cadherin, β-catenin) at 
the plasma membrane and with APC (Willert and Nusse 1998). Mutation of 
serine/threonine residues stabilizes β-catenin, mimicking an increased Wnt signal. 
Recently, LGRs, which are seven transmembrane proteins, were shown to mark stem 
cell (SC) populations (Jaks, Barker et al. 2008), to physically interact with 
Frizzled/LRP receptors, and to act in R-spondin-mediated Wnt signaling (de Lau, 
Barker et al. 2011; Carmon, Lin et al. 2012; Clevers and Nusse 2012). 
 
2.2.2 BMP signaling 
Bone Morphogenetic Protein (BMP) signaling consists of two superfamilies of 
ligands: (a) the BMP family comprising BMPs, GDFs (Growth and Differentiation 
Factors), and MIS (Muellerian Inhibiting Substance) and (b) the Transforming Growth 
Factor (TGF)β family comprising TGF I, II, III, Activin, and Nodal. BMP ligands 
have higher affinity to type I BMP receptors, while TGF family ligands have higher 
affinity to type II receptors. Type I and II receptors carry an N-terminal ligand-binding 
domain, a transmembrane domain, and a C-terminal serine/threonine kinase domain 
(Pelton, Saxena et al. 1991; Shi and Massague 2003). TGFβ/Activin ligands seem to 
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first bind to type II receptors resulting in a conformational change that enables type I 
receptors to bind to the complex. Upon activation, receptors can directly 
phosphorylate R-Smad which releases R-Smad for its binding to Co-Smad (Smad4) 
and for further localization into the nucleus where it binds the DNA and regulates 
transcription along with other co-factors (Shi and Massague 2003). R-Smads (Smad 
2/3 for TGFβ and Smad 1/5/8 for BMP family) are normally bound to type I receptor 
in an inactive state. The BMP-related ligands can be bound and inhibited by inhibitors 
such as Noggin or Follistatin (Schmidt-Ullrich and Paus 2005). 
 
2.2.3 Shh signaling 
The mammalian Hedgehog family consists of three secreted proteins: Sonic 
Hedgehog (Shh), Indian Hedgehog and Desert Hedgehog (Athar, Tang et al. 2006). 
Patched1, a twelve-span transmembrane protein that acts as a Shh antagonist, normally 
represses Smoothened (Smo), a seven-span transmembrane co-receptor. Shh signaling 
inhibits Patched1 thereby relieving the repression of Smo, which can now activate Gli 
proteins which serve as transcriptional effectors (Callahan and Oro 2001). Each Gli 
gene (Gli1, 2, and 3) has varying expression patterns in different time and location 
with differential impact on tissue development and physiology (Matise, Epstein et al. 
1998; Matise and Joyner 1999; Park, Bai et al. 2000). 
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2.2.4 Notch signaling 
Notch is a single-span transmembrane protein, originally identified in 
Drosophila (Kopan and Ilagan 2009), with four family members Notch1, 2, 3, and 4 
identified in mammals. The extracellular domain of Notch carries Epidermal Growth 
Factor (EGF)-like repeats and is activated upon ligand-binding (Delta or Jagged) from 
neighboring cells. The activation signal triggers ADAM, a metalloproteinase, to cleave 
Notch before the transmembrane domain and release the intracellular domain from the 
membrane. The ADAM cleaved product of Notch acts as a substrate for γ-secretase, 
which cleaves and subsequently releases NICD (Notch Intra-Cellular Domain) for its 
translocation into the nucleus, where it forms a complex with CBF1/RBPj/Su(H)/Lag-
1 for transcriptional activation (Kopan and Ilagan 2009). 
 
2.2.5 Other signaling pathways  
EGFs and TGFβ bind to EGF-Receptors (EGFRs), and this binding triggers 
dimerization of the receptors and auto-phosphorylation of tyrosine residues, leading to 
transcriptional activation through Src-Homology proteins, ultimately resulting in cell 
proliferation (Ullrich and Schlessinger 1990; Pawson and Schlessingert 1993). In 
particular, EGF molecules promote robust keratinocyte proliferation (Barrandon and 
Green 1987). Fibroblast Growth Factor (FGF) ligands signal through FGF receptors 
that are tyrosine-kinases and regulate various cellular processes such as proliferation, 
migration, and differentiation (Yamasaki, Miyake et al. 1996). 
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2.2.6 Hair follicle specification, generation, and maintenance during development 
and skin homeostasis 
Skin epithelium arises from the single layer of ectoderm that surrounds the 
embryo body during embryonic development (Blanpain and Fuchs 2006). Cells of the 
basal layer (BL) produce highly keratinized terminally differentiated cells of the 
suprabasal layers that form the interfollicular epidermis. Starting around E14.5, 
epithelial–mesenchymal signaling triggers BL cells of the epithelium to aggregate, 
forming a hair placode (Figure 2.1) (Hardy 1992; Tumbar 2012), which proliferate and 
form a hair germ (HG). The mesenchymal cells residing below start to condense, and 
as the HG becomes a “peg”, they become engulfed in the epithelium forming the 
“dermal papilla” (DP). Soon after, the highly proliferative cells at the bottom of the 
peg become matrix (Mx) cells, and start producing inner layers, terminally 
differentiated HF lineages, forming a bulbous peg (Figure 2.1). Meanwhile, cells on 
one side of the upper outer root sheath (ORS) cluster, forming a bulge structure that 
would later contain HFSCs. The sebaceous gland (SG) is also generated from the 
epithelial HF cells (Frances and Niemann 2012). Melanocytes are a separate lineage 
that originates from the neural crest, resides in the bulge and Mx, and produces 
melanin that incorporates into the differentiated hair shaft for color. The HF 
compartmentalization and differentiation lasts up to ∼2.5 weeks after mouse birth 
(Schmidt-Ullrich and Paus 2005; Blanpain and Fuchs 2006).  
After a period of hair growth known as anagen, cells in the lower HF portion 
undergo apoptosis and HF regresses during the catagen phase, which brings the DP in 
close proximity to the bulge (Figure 2.2). Around ∼PD21 HF enters quiescence or rest  
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Figure 2.1. Signaling in hair follicle morphogenesis and development 
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Figure 2.2. Adult hair follicle signaling from quiescence to activation 
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(telogen), but is ready to re-activate upon signaling from the DP and the environment. 
During adult homeostasis, HF undergoes cycles of anagen, catagen and telogen, 
referred to as “hair cycle” (Cotsarelis 2006). HFSCs reside in the bulge and are the 
source that fuels all HF lineages (Cotsarelis, Sun et al. 1990; Fuchs, Tumbar et al. 
2004; Claudinot, Nicolas et al. 2005). At telogen, upon activation signals, some bulge 
SCs migrate out into HG where they lose SC characteristics and become progenitors 
that start to divide rapidly (Zhang, Cheong et al. 2009). The remaining bulge cells 
divide ∼3×during one hair cycle to replenish their SC pool (Waghmare, Bansal et al. 
2008; Zhang, White et al. 2010). Rapid proliferation of progenitors (or Transit-
Amplifying (TA) cells) results in formation of Mx cells, which give rise to 
differentiated HF lineages, similar to the anagen of morphogenesis (Muller-Rover, 
Handjiski et al. 2001). In catagen, cells in the lower HF die again, followed by re-
arrangement of the upper and mid ORS cells around the new club hair and the germ, 
respectively (Hsu, Pasolli et al. 2011). Upon injury conditions such as hair plucking, 
waxing, and wounding, HFSCs are activated and produce not only HFs but also 
contribute to epidermal regeneration (Blanpain and Fuchs 2006). 
Around the HF, other organs and tissue structures aid in HF homeostasis. The 
Arrector Pili Muscle (APM) provides the physical force in HF erection necessary for 
body temperature and appearance (Fujiwara, Ferreira et al. 2011). Recent evidence 
suggests that Nephronectin, a Wnt-target gene, is enriched in the bulge and this subset 
of bulge cells serve as a niche for muscle cells. Also, vascularization regulated by 
VEGF is essential for creating a nurturing environment around the HF (Yano, Brown 
et al. 2001; Beck, Driessens et al. 2011). In addition, surrounding adipocytes are 
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important for HF cycling, in which PDGF signaling plays a role (Festa, Fretz et al. 
2011). Aberrant signaling is associated with various skin conditions such as 
pilomatricoma, basal cell carcinomas (BCCs), hamartoma, etc. (Gailani, Stahle-
Backdahl et al. 1996; Hahn, Wicking et al. 1996; Dahmane, Lee et al. 1997; Oro, 
Higgins et al. 1997; Gat, DasGupta et al. 1998; Xie, Murone et al. 1998; Chan, Gat et 
al. 1999; Grachtchouk, Mo et al. 2000; Nilsson, Unden et al. 2000; Callahan and Oro 
2001; Nakamura, Sundberg et al. 2001; Grachtchouk, Grachtchouk et al. 2003; Mill, 
Mo et al. 2003; Ming Kwan, Li et al. 2004; Yuhki, Yamada et al. 2004), indicating the 
importance of maintaining the balance of signaling cascades. A comprehensive review 
underlining the relevance to human disease has been recently published (Boehnke, 
Falkowska-Hansen et al. 2012). Perhaps the best understood is the aberrations that 
result from perturbation of the Shh signaling cascade. Components of Shh signaling 
cascade such as Patched1, Gli1, Smo, and Shh are expressed at high level in many 
BCCs, and over-expression of individual molecules resulted in BCC-like tumor 
formation (Gailani, Stahle-Backdahl et al. 1996; Hahn, Wicking et al. 1996; Dahmane, 
Lee et al. 1997; Oro, Higgins et al. 1997; Xie, Murone et al. 1998; Athar, Tang et al. 
2006). Here, we classify these important signaling pathways based on the stage of HF 
remodeling upon which they act and suggest areas that require further exploration. 
 
 
2.3 Signaling during hair follicle development 
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2.3.1 Initiation of hair follicle morphogenesis 
Wnt signaling is critical for HF induction (Alonso and Fuchs 2003). Wnt10a, 
Wnt10b, nuclear -catenin and Lef1 are expressed in the hair placode epithelium 
(Vangenderen, Okamura et al. 1994; Zhou, Byrne et al. 1995; Merrill, Pasolli et al. 
2004), while Wnt5a is expressed in the mesenchyme right below the placode (Reddy, 
Andl et al. 2001). Targeted deletion of β-catenin in the epithelium via Keratin 14 (K14) 
promoter active in the BL and ORS inhibits hair placode formation (Huelsken, Vogel 
et al. 2001), and down-regulation of Lef1, Bmp2, Bmp4, Bmp7, Shh, and Patched1. 
Similarly, over-expression of Dkk1 results in absence of β-catenin, Wnt10b, Lef1, 
Edar, Bmp2, Bmp4, Gli1, and K17, and lack of hair placode (Andl, Reddy et al. 2002). 
Conversely, constitutively active β-catenin induces precocious placode formation and 
multiple HG budding out from the original follicle (Gat, DasGupta et al. 1998; Silva-
Vargas, Lo Celso et al. 2005; Zhang, Andl et al. 2008). β-Catenin and Hedgehog 
signal strength can specify the number and location of HFs in adult epidermis without 
recruitment of bulge SCs. 
Lef1 skin knockout reduces the HF numbers (Vangenderen, Okamura et al. 
1994) and whisker follicle induction, but expression of Lef1 in the dermis at E11.5 
rescues this phenotype (Kratochwil, Dull et al. 1996), suggesting a critical role for 
mesenchymal Lef1. Transgenic Wnt reporter mice containing multiple Lef/Tcf 
binding sites (TOPGAL) shows activity in the placode as well as in the underlying 
mesenchyme, which correlates with Lef1 protein localization (DasGupta and Fuchs 
1999). Other Wnt-related transcription factors, Tcf3 and 4 are also in the placode, but 
fade away as HF undergoes further down-growth (Nguyen, Rendl et al. 2006). Double 
  42 
knockout of Tcf3/4 display loss of hair and thinning of skin (Nguyen, Merrill et al. 
2009). 
Aside from Wnt-related molecules, the placode expresses Bmp2, Bmp7, and 
Shh while the underlying mesenchyme expresses Noggin, Bmp4, Patched1, and Gli1 
(Reddy, Andl et al. 2001; Andl, Reddy et al. 2002). Deletion of Noggin reduces 
epithelial placode density except for the guard hairs. A few placodes that form display 
cytoplasmic localization of β-catenin, which is rescued by Lef1 over-expression 
(Botchkarev, Botchkareva et al. 1999; Jamora, DasGupta et al. 2003). As epithelial 
invagination begins, the placode down-regulates E-Cadherin and gains expression of 
P-Cadherin. E-Cadherin failed to be down-regulated in Noggin knockout mice, and 
this was also rescued by Lef1 (Jamora, DasGupta et al. 2003).  
FGF7 and FGF2 over-expression in K14-lineages also reduce HF density, but 
display epidermal hyper-proliferation, suggesting that FGF signaling may promote 
epidermal instead of HF cell fate choice (du Cros 1993; Guo, Yu et al. 1993). While 
FGF7 null mice does not show a significant phenotype (Guo, Degenstein et al. 1996), 
over-expression of FGF7 dominant negative form in skin results in defects in HF 
production and significant reduction in proliferation upon wounding (Werner, Smola 
et al. 1994). In summary, high level of Wnt signaling and suppression of BMP and 
FGF signaling are required for epidermal cell fate choice toward HF cells and allow 
these cells to aggregate and begin to invaginate to form the hair placode. 
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2.3.2 Follicular invagination and maturation 
Shh knockout or knockdown show initial epithelium invagination and 
mesenchymal condensation, but HFs become developmentally arrested at this stage 
(St-Jacques, Dassule et al. 1998; Chiang, Swan et al. 1999; Wang, Liu et al. 2000). 
Shh transcriptional targets (Ptc1, Smo, Gli1 and Gli2) are detected at lower levels, but 
Wnt and Bmp signaling are unaffected by the Shh knockout, suggesting that Shh 
signaling is not critical for initial placode formation but is important for HF growth. 
Gli2 knockout mice show similar phenotype to the Shh knockout mice (Mill, Mo et al. 
2003). K14-ΔNβ-catenin mice show aberrant expression pattern of Shh, often on both 
sides of Mx, and this is associated with wavy HFs, suggesting that asymmetric Shh 
localization in the Mx is critical for follicular polarity (Gat, DasGupta et al. 1998). 
Wnt signaling plays important roles during follicular growth. For instance, 
Wnt3 expression is confined to differentiating hair medulla (Millar, Willert et al. 
1999). Dvl2, another important player of the Wnt pathway, co-localizes with AE13+ 
differentiated cortex layer. K14-Wnt3 and K14-Dvl2 transgenesis result in shortening 
of hair shafts. In addition, Wnt10a/Wnt10b are in the IRS precursors while Wnt5a is 
expressed in the DP and a subset of ORS cells. Wnt11, Wnt3a, and Wnt4 are present 
in specific HF layers during maturation (Reddy, Andl et al. 2001). Nuclear Lef1 is 
confined to the tip of the growing follicle and the mesenchyme touching the tip. At 
birth, Lef1 mRNA is found in the Mx and pre-cortical region, and Lef1 protein nuclear 
localization becomes strong in the pre-cortex (DasGupta and Fuchs 1999). 
Interestingly, TOPGAL mice show significant signal enrichment in the hair cortex. On 
the other hand, Tcf3 is not expressed in the Mx but in the lower ORS.  
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Targeted deletion of β-catenin in melanocyte SCs results in loss of hair 
pigmentation, along with reduced proliferation and absence of differentiation markers 
(Rabbani, Takeo et al. 2011). Interestingly, induction of β-catenin dominant active 
form in K15 lineage results in expansion of melanocytes, promoting their proliferation. 
This seemed to be regulated through Edn, a direct Wnt target gene that is highly 
induced upon β-catenin activation in epithelial cells, and concomitant increased 
expression of EdnrB in melanocyte SCs. 
Bmp signaling is critical for proper HF differentiation. Bmpr1a deletion results 
in abnormal HF formation due to reduced p-Smad1/5/8 levels through which Bmp 
signaling occurs along with a lack of lineage-specific differentiation markers (Andl, 
Ahn et al. 2004). 
In conjunction with common signaling pathways, different hair types (vibrissae, 
guard, and pelage) seem to employ slightly different signals for HF induction. For 
instance, EdaA1/EdaR signaling through NF-κB is essential for guard hair 
specification (Headon and Overbeek 1999; Mikkola, Pispa et al. 1999; Schmidt-
Ullrich, Aebischer et al. 2001). On the other hand, mutations in ActivinA or its 
inhibitor Follistatin results in defects in development of vibrissae and pelage HFs 
(Munz, Smola et al. 1999; Laurikkala, Pispa et al. 2002; Nakamura, Matzuk et al. 
2003). Sox2 is expressed in DP of “some” but not all HF types and is important for the 
specification of these follicular types (Driskell, Giangreco et al. 2009). 
While Mx cells give rise to differentiated HF lineages, one side of upper ORS 
cells generate a cluster, forming the bulge, which contains adult HFSCs that are 
essential for adult HF cycling and skin homeostasis. These differential fates seemed to 
  45 
be specified early in the placode stage, where there is heterogeneity of several 
molecular markers such as Shh (Levy, Lindon et al. 2005), Sox9 (Nowak, Polak et al. 
2008), Lgr6 (Snippert, Haegebarth et al. 2010), Tbx1 (Chen, Heller et al. 2012) and 
Runx1 (Osorio, Lilja et al. 2011) expression in all or a subset of cells in the placode. 
Lineage tracing experiments showed that these placode cells give rise to ORS, bulge, 
and other HF lineages (Tumbar 2012). More importantly, these factors interact with 
signaling molecules in regulating proper HF development. For instance, Runx1 
expression is detected in a subset of placode cells as well as in mesenchyme in the 
very early stage of morphogenesis. Runx1 expression becomes very prominent 
through the growing follicle as well as in DP, and interacts with Lef1 in differential 
mediation of Wnt signaling for proper emergence and maintenance of HFSCs (Osorio, 
Lilja et al. 2011). Runx1 expressing cells eventually give rise to adult HFSCs, and 
Runx1 plays additional roles in their proliferation in adulthood (Osorio, Lee et al. 
2008; Hoi, Lee et al. 2010). Mature HFs are compartmentalized and can be 
characterized by specific expression profiles. The Gli1+ region above the bulge and 
the Lrig1+, Mts24+, Lgr6+, and Blimp1+ region of the isthmus and SG bear SCs, but 
these do not contribute to long-term HF regeneration (Horsley, O'Carroll et al. 2006; 
Nijhof, Braun et al. 2006; Jensen, Collins et al. 2009; Snippert, Haegebarth et al. 2010; 
Brownell, Guevara et al. 2011). 
In addition to Wnt, Bmp, and Shh signaling, Notch signaling also ensures 
proper HF differentiation. Notch1 is expressed in the Mx. Notch2 is not detected, but 
Notch3 and Jagged1 are expressed in pre-cortex cells and cuticle layer of IRS (Watt, 
Estrach et al. 2008). Over-expression of Notch1 Intra-Cellular Domain (NICD) in pre-
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cortical and cortical cells results in hair loss at the end of 1st hair cycle and displays 
abnormal differentiation (Lin, Leimeister et al. 2000; Uyttendaele, Panteleyev et al. 
2004). Loss of Notch1/2 as well as loss of RBPjκ or γ-secretase in epithelium, result in 
initiation of HF morphogenesis, but show similar defects of abnormal differentiation 
followed by hair loss (Pan, Lin et al. 2004; Blanpain, Lowry et al. 2006; Cai, Lee et al. 
2009; Demehri and Kopan 2009). RBPjκ deletion in DP (ColICre) also shows 
disrupted IRS followed by HF degeneration and cyst formation (Hu, Lefort et al. 
2010). In addition, Wnt5a, Fgf7, Fgf10 and Noggin are down-regulated in the DP and 
re-introduction of these factors partially rescued the HF degeneration phenotype. 
These results suggest that Notch1 signaling controls DP signature molecules that in 
return signal to the Mx cells to differentiate.  
Importantly, Notch signaling works downstream of several pathways. For 
instance, ectopic expression of constitutively active β-catenin in K14-lineages results 
in up-regulation of Notch pathway genes such as Jagged1, suggesting a Wnt-
dependent regulation of Notch signaling (Estrach, Ambler et al. 2006; Ambler and 
Watt 2007; Watt, Estrach et al. 2008). Msx2 and Foxn1 seem to play redundant roles 
in regulating Notch1 expression and are important for proper HF differentiation. 
Interestingly, Bmpr1a deficient mice display reduction in Msx2 and Foxn1 expression 
in the HF and show similar phenotype to Msx2/Foxn1 double mutant, suggesting that 
BMP signaling from Mx/DP regulate Msx2/Foxn1-mediated Notch1 expression in 
proper HF differentiation (Andl, Ahn et al. 2004; Cai, Lee et al. 2009). Finally, 
EGF/TGFβ molecules are also detected in the hair bulb and IRS and in the absence of 
  47 
TGFβ, HFs become wavy and curly, displaying an abnormal differentiation (Luetteke, 
Qiu et al. 1993; Mann, Fowler et al. 1993). 
 
2.3.3 Regression and quiescence of mature hair follicle 
Around ∼PD16–17, the lower portion of the mature HF is destructed by 
apoptosis (catagen). DP moves upward and comes in close contact to the bulge, and 
the HF enters telogen phase around ∼PD20–21. Interestingly, targeted deletion of β-
catenin in the DP (Corin-Cre) around PD3 during HF growth phase, results in 
premature entrance into catagen (Enshell-Seijffers, Lindon et al. 2010). Dlx3, a Dlx-
related transcription factor, regulates timely HF regression from the epithelial 
compartment (Hwang, Mehrani et al. 2008). Dlx3 expression extends from Mx to IRS, 
and Lef1 regulates its expression. Dlx3 mutant HFs show enhanced proliferation along 
with delayed regression due to the absence of BMP signaling (Hwang, Mehrani et al. 
2008). FGF5 is expressed in late anagen during morphogenesis, and its deletion delays 
catagen, resulting in longer hair shafts (Enshell-Seijffers, Lindon et al. 2010). 
In summary, multiple signals including Wnt, Bmp, Shh, Notch, FGF and EGF 
are at work in proper follicular morphogenesis: growth, lineage specification, and 
timely regression after maturation. Interestingly, a handful of the same signaling 
pathways are utilized in both formation and maturation of the HFs. However, the 
different combinations of these pathways during a specific time window and cell 
populations likely program the cells to distinct fates. 
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2.4 Signaling in hair follicle cycling during homeostasis and injury 
2.4.1 From quiescence to activation   
The adult hair cycle begins at first telogen (∼PD20–21) after HFs finished 
regression and await activation (Figure 2.2). HF quiescence is maintained via Bmp 
signaling (Rendl, Lewis et al. 2005). Specifically, Bmp4 is expressed in DP and 
secondary HG while Noggin, a Bmp inhibitor, is absent in telogen follicle. On the 
other hand, Bmpr1a is expressed in HG and in SG (Botchkarev, Botchkareva et al. 
2001). In addition, Bmp2/4 levels are highest at telogen. Inhibition of Bmp signaling 
via Noggin over-expression resulted in precocious anagen entrance upon hair plucking, 
suggesting a dominant role of Bmp signaling in maintaining quiescence (Plikus, 
Mayer et al. 2008). HFSCs quiescence is also maintained via Bmp regulation of 
NFATc1, a bulge-specific marker that once lost results in increased proliferation 
(Horsley, Aliprantis et al. 2008). A recent study also suggests that TGFβ signaling is a 
major pathway regulating the adult hair cycle (Oshimori and Fuchs 2012). TGFβ 
receptor II (TGFβRII) activity and p-Smad2 were detected in the lower bulge and the 
HG at the transition from telogen to anagen. In addition, late-telogen DP is enriched 
with TGFβ2 ligand and injection of TGFβ2 ligand in the TGFβRII knockout mice 
before endogenous TGFβ2 expression in DP failed to activate anagen at a normal time 
due to a direct regulation of Tmeff1, a transmembrane protein that inhibits BMP 
signaling (Oshimori and Fuchs 2012). Moreover, the inner layer (K6+) of the bulge 
expresses significant amounts of Bmp6 and Fgf18, which inhibit the outer bulge stem 
cell layer (CD34+) proliferation (Figure 2.2). Fgf18 deletion in Keratin 5 (K5)+ cells 
(BL and ORS) results in shorter telogen length before anagen re-entry. In addition, 
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subcutaneous Fgf18 as well as BMP and Wnt inhibitors all induce HF quiescence 
(Plikus, Baker et al. 2011; Kimura-Ueki, Oda et al. 2012). Finally, ablation of the 
inner bulge layer (K6+) induces bulge cell proliferation, suggesting a paracrine role of 
Bmp6 and Fgf18 in maintaining bulge SC quiescence (Hsu, Pasolli et al. 2011). 
Upon activation, Bmp4 expression in DP and HG decreases while the rest of 
the skin dermis shows Bmp4 up-regulation (Kobielak, Stokes et al. 2007). 
Concomitantly, DP and the growing HG up-regulate Noggin and down-regulate 
Bmpr1a. Deletion of Bmpr1a in telogen following shaving results in precocious bulge 
cells proliferation, but no further development of HF. Concomitantly there is loss of 
CD34 in the bulge as well as Sox9 and Lhx2 expression in the HG (Kobielak, Stokes 
et al. 2007). In addition, the bulge shows increased nuclear β-catenin and Lef1, which 
is mediated by inactivation of GSK-3β by its increased phosphorylation, potentially 
driven by PTEN/PI3-K/P-Akt pathway.  
Low level of Wnt signaling is also essential for maintaining HF quiescence. 
K14-ΔNβ-catenin hemizygous mice display precocious anagen activation, revealing a 
dose-dependence of β-catenin in hair cycle activation (Lowry, Blanpain et al. 2005). 
In addition, inducible ectopic expression of activated β-catenin in the 2nd telogen 
results in precocious induction of anagen-like HF structure associating hyper-
proliferation as well as induction of de novo sites of HF formation (Van Mater, Kolligs 
et al. 2003; Lo Celso, Prowse et al. 2004). Lef1 is absent in the bulge, but is enriched 
in HG during telogen. On the other hand, Tcf3/4 are highly enriched in the bulge, 
originating from the embryonic Tcf3/4 expressing cells of the ORS (Nguyen, Rendl et 
al. 2006), acting as a repressor of Wnt signaling (Merrill, Gat et al. 2001; Nguyen, 
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Merrill et al. 2009). Conversely, Wnt10a/Wnt10b are enriched in the bottom of the 
HG and in DP at telogen–anagen transition (Reddy, Andl et al. 2001). FGF7 
expression gradually increases in DP during the long 2nd telogen prior to activation. 
Moreover, ectopic Fgf7 induction in telogen results in proliferation induction in the 
HG (Greco, Chen et al. 2009). Some of the Wnt pathway genes may be regulated by 
Runx1, which is present in the lower bulge and HG and governs timely HFSCs 
activation and proliferation (Osorio, Lee et al. 2008; Hoi, Lee et al. 2010). 
Lgr5, a protein that is enriched in a subset of cells in the lower bulge and the 
HG in telogen bear multipotency and seem to have Wnt-dependent function. In vitro 
and biochemical assays revealed that LGR proteins bind to Frizzled and LRP receptors 
forming a complex, which can activate canonical Wnt signaling pathway (Jaks, Barker 
et al. 2008; de Lau, Barker et al. 2011; Carmon, Lin et al. 2012). The role of these 
LGR proteins in HF in vivo has not yet been addressed.  
Recently, a circadian molecular clock mediated via Bmal1/Clock transcription 
factors was shown to affect HFSCs proliferation and quiescence through de-regulation 
of many critical signaling molecules such as Wnt-related (Dkk3, Lef1, Fzd2/3, Sox9, 
Lhx2, Lgr5, and Tcf3) and Bmp-related (Smad7, Ltbps, and Lefty) (Janich, Pascual et 
al. 2011). Wnt, Bmp, and Fgf interactions counterbalance each other inhibitory and 
activation signals and predispose telogen follicles to be at a “refractory” or “competent” 
status with respect to anagen entry (Plikus 2012). The “waves” of some of these 
signaling molecules traveling as gradients throughout the mouse skin across the body 
may be the consequence of fluctuations of the components in the circadian clock that 
regulate signaling pathway genes. 
  51 
 
2.4.2 Growth and differentiation of adult hair follicle 
Growth and differentiation of adult HF employs similar signaling as 
morphogenesis. Mx cells and pre-cortex cells express Wnt3 and Wnt10a/b (Reddy, 
Andl et al. 2001). These molecules send cascades of signaling to Lef1, which also 
show enrichment in the Mx and pre-cortical cells (DasGupta and Fuchs 1999). In 
addition, differentiated layers express many Wnt molecules such as Wnt3a, Wnt4, and 
Wnt11. 
In addition to Wnt signals, a variety of Bmp ligands and receptors are 
expressed in the Mx cells (Bmpr1a/b and Bmpr2), hair shaft precursors (Bmp2/4), and 
IRS lineages (Bmp7/8), which allow the TA cells to stop proliferation and enter the 
terminal differentiation program (Rendl, Lewis et al. 2005). Moreover, surrounding 
the HF, Bmp2/4 are present at low level in the mesenchyme during early anagen. 
These levels gradually peak at the late anagen and telogen to inhibit proliferation 
(Plikus, Mayer et al. 2008). 
The extent of bulge SC proliferation during anagen seems to inversely 
correlate with the level of BMP ligands (Waghmare, Bansal et al. 2008; Zhang, 
Cheong et al. 2009). During anagen, bulge SCs self-renew to make up for the loss that 
occurred prior to anagen activation (Zhang, Cheong et al. 2009). Extended self-
renewal push cells out downward into the ORS region below the bulge, which later 
move upwards to make a new bulge and HG (Hsu, Pasolli et al. 2011). Although to a 
lesser extent than the inner bulge layer (K6+), bulge SCs (CD34+) express Bmp6 and 
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Fgf18 that seems to send the inhibitory signal toward the ORS cells in regulating their 
proliferation during anagen (Blanpain, Lowry et al. 2004; Greco, Chen et al. 2009). 
Notch signaling is also important for proper adult HF differentiation, 
 as it was for the developing HF during morphogenesis. RBPjκ targeted deletion in the 
bulge (K15+) at 2nd telogen results in normal HF activation and growth, but HFs 
display abnormal terminal differentiation, and in long-term form cysts containing 
epidermal lineage keratinocytes (Demehri and Kopan 2009). 
 
2.4.3 Destruction and returning back to quiescence in adulthood 
Once the proliferative signal fades and inhibitory signals accumulate in the 
anagen–catagen transition, HF starts to regress from the bottom. TGFβ1 expression is 
seen in bulge and ORS in early anagen, followed by enrichment in ORS in late anagen 
(Foitzik, Lindner et al. 2000). Its expression increases in catagen in the bulge and the 
epithelial strands, and disappears in telogen. TGFβ1 deletion resulted in delayed 
catagen entrance, and ectopic TGFβ1 expression induced premature catagen, 
suggesting its importance in timing the switch from proliferation to regression. 
BMP signals start to accumulate from late anagen, last throughout catagen, and 
peak at telogen (Plikus, Mayer et al. 2008). Also, Fgf18 starts to be expressed in 
catagen and is maintained throughout telogen. Ectopic induction of Fgf18 in anagen 
shows reduction in proliferation, suggesting its up-regulation during hair cycle may be 
important for inducing catagen (Kimura-Ueki, Oda et al. 2012). EGFR expression is 
detected in the ORS (Luetteke, Phillips et al. 1994). Dominant negative EGFR showed 
initial HF formation, but failed to enter catagen and resulted in hair loss over time 
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(Murillas, Larcher et al. 1995). Other signaling molecules such as neurotrophins have 
also revealed their importance in proper regression (Botchkarev, Welker et al. 1998; 
Botchkarev, Botchkareva et al. 1999; Botchkareva, Botchkarev et al. 2000; 
Botchkarev, Botchkareva et al. 2001).  
In summary, Bmp-mediated repression dominantly contributes to adult HF and 
HFSCs quiescence, and accumulation of Wnt or other signals are necessary to 
overcome and lead cells into proliferation. HF bulge cells display extra quiescence 
relative to other HF compartments due to autocrine and paracrine Bmp and Fgf signals 
that are innate (from the CD34+ bulge cells) and secreted from the surrounding 
mesenchyme and the inner bulge layer (K6+). Wnt, Bmp, Shh, Notch, and Egf signals 
are important for proper adult HF growth and differentiation program. Finally, gradual 
buildup of Bmp and Fgf signals overtake the proliferative signals, induces HF 
regression followed by quiescence (telogen). 
 
2.4.4 The curious case of Runx1: when timing and localization matters  
As described so far, the growth and differentiation of HF during the 
morphogenesis and hair cycling resemble each other in their cellular and molecular 
processes. However, a major difference is that while secondary (adult) HG consists of 
short-lived progenitors, the primary (embryonic) HG contains precursors that would 
later give rise to long-lived HFSCs. Interestingly, there is strong and transient 
expression of Runx1 in the embryonic dermis, which molecularly distinguishes 
embryonic from adult skin. This coincides with another unique, non-cyclic, event in 
the life of the HF: the birth of adult HFSCs (Osorio, Lilja et al. 2011). When Runx1 is 
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knocked out in the mesenchyme during this stage, HF form and go through the first 
catagen but adult HFSC cells convert their fates toward SG later on in life. Strikingly, 
Runx1 regulates autocrine and paracrine Wnt signaling in opposing direction in the 
dermis versus epidermis, thereby creating gradients of signaling in the embryonic skin. 
Thus, loss of Runx1 in the mesenchyme at the embryonic stage revealed the 
importance of Wnt signaling in the embryonic environment to nurture the nascent 
adult HFSCs to mature well, to shape up their molecular makeup and to endow them 
with long life and multipotency. 
 
2.5 Conclusions and future perspectives 
In this review, we summarized our current understandings of signaling pathways 
that play essential roles in governing the development and cycling of HFs. Mouse 
genetics allowed researchers to discover the tip of the iceberg in the molecular 
networks that are participating in the greater purpose of tissue development and 
homeostasis. Perturbation in these pathways leads to disease and some of the signals 
unveiled here are already making their useful way to the clinic. As with most human 
disease, those affecting skin are likely subtly affecting multiple genes and are difficult 
to model by gene knockout. The generation of induced pluripotent SCs (iPS) 
(Takahashi and Yamanaka 2006) and the ability to differentiate them to keratinocyte 
(Hanna, Wernig et al. 2007) combined with high throughput sequencing might allow 
us not only to identify those gene variations that are possibly associated with disease, 
but also to model these diseases by regenerating skin and hair follicles from human 
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iPS in immune-compromised mice. Advances in transgenic mouse technology allow 
us to relatively easily study single gene mutations (Dow and Lowe 2012) and may in 
the future be adapted to rapidly create multiple mutations that can mimic specific traits 
discovered in human disease. 
The advances within the field have begun to uncover the veil of skin biology, 
pointing the researchers to the areas of further exploration. How are signals sent from 
dermis, adipocytes, blood vessels, and inner bulge cells regulated? To what degree do 
paracrine and autocrine signals that surround or are innate influence the HF status? 
Are there more signaling pathways waiting to be discovered? What is the degree of 
redundancy across different activation or inhibitory signals? How can these signaling 
networks be used or manipulated in medical purpose of treating patients with skin 
diseases or wounds? Answers to these questions will bring insights in discovering 
what remains below the tip of the iceberg of skin biology.
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CHAPTER 3 
RUNX1 AND P21 SYNERGISTICALLY LIMIT THE EXTENT OF HAIR 
FOLLICLE STEM CELL QUIESCENCE IN VIVO
2
  
 
3.1 Summary 
Mechanisms of tissue stem cell (SC) quiescence control are important for 
normal homeostasis and for preventing cancer. Cyclin-dependent kinase inhibitors 
(CDKis) are known inhibitors of cell cycle progression. We document CDKis 
expression in vivo during hair follicle stem cell (HFSC) homeostasis and find p21 
(cyclin-dependent kinase inhibitor 1a, Cdkn1a), p57, and p15 up-regulated at 
quiescence onset. p21 appears important for HFSC timely onset of quiescence. 
Conversely, we find that Runx1 (runt related transcription factor 1), which is known 
for promoting HFSC proliferation, represses p21, p27, p57, and p15 transcription in 
HFSC in vivo. Intriguingly, in cell culture, tumors, and normal homeostasis, Runx1 
and p21 interplay modulates proliferation in opposing directions under the different 
conditions. Unexpectedly, Runx1 and p21 synergistically limit the extent of HFSC 
quiescence in vivo, which antagonizes the role of p21 as a cell cycle inhibitor. 
Importantly, we find in cultured keratinocytes that Runx1 and p21 bind to the p15 
promoter and synergistically repress p15 mRNA transcription, thereby restraining cell 
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cycle arrest. This documents a surprising ability of a CDKi (p21) to act as a direct 
transcriptional repressor of another CDKi (p15). We unveil a robust in vivo 
mechanism that enforces quiescence of HFSCs, and a context-dependent role of a 
CDKi (p21) to limit quiescence of SCs, potentially by directly down-regulating 
mRNA levels of (an)other CDKi(s). 
 
3.2 Materials and Methods 
Mice  
All mice were treated according to Cornell University Institutional Animal 
Care and Use Committee protocols. To generate H2B-GFP and p21 (Cdkn1a) mice, 
we crossed each of K5-tTA (CD1) and pTRE-H2BGFP (Tumbar, Guasch et al. 2004) 
(FVB) mice to Cdkn1a−/− mice (Jackson Laboratories strain B6;129S2-Cdkn1atm1Tyj/J, 
#003263). The K14-Cre (CD1, from E. Fuchs, Rockefeller University, New York, NY) 
line was mated with Runx1
fl/fl 
(C57BL/6, from N. Speck, University of Pennsylvania, 
Philadelphia, PA), which was further mated with Cdkn1a−/− mice to generate dKO 
mice and all of the different genotypes. The crossing steps were designed to keep the 
ratio of genetic backgrounds constant for reducing variability of the TPA/DMBA 
treatment. BrdU was injected intraperitoneally in PBS at 25μg/g of body weight 2hrs 
before mice were killed. 
 
DMBA/TPA Treatments 
 74 
DMBA (7,12-Dimethylbenz(a)anthracene)/TPA (12-O-tetradecanoylphorbol-
13-acetate) treatments were carried out according to (Hennings, Glick et al. 1993). 
Briefly, (i) K14-Cre+; Runx1
fl/+
; Cdkn1a
+/+
, (ii), K14-Cre+; Runx1
fl/+
; Cdkn1a
−/−
, (iii) 
K14-Cre+; Runx1
fl/fl
; Cdkn1a
+/+
, and (iv) K14-Cre+; Runx1
fl/fl
; Cdkn1a
−/−
 mice were 
obtained by parallel crosses to keep a constant genetic background mix. Their back 
skins were treated with a single dose of 32μg of DMBA in 200μL of acetone at second 
telogen [between postnatal day (PD) 60 and PD 90]. Then we biweekly applied 
12.4μg/body weight of TPA dissolved in 200μL of acetone per each treatment for 
20wk (total 40 TPA treatments). The hair was shaved for efficient delivery of TPA as 
well as to count the number of papillomas. Mice were monitored weekly for papilloma 
counts. 
 
H2B-GFP Pulse-Chase System 
H2B-GFP fusion protein is expressed under Keratin 5 (K5)-tTA control, which 
is shut off by feeding the mice with doxycycline (chase). Upon cell division, H2B-
GFP intensity is halved, allowing division counting during the chase. H2BGFP mRNA 
production is tightly controlled upon doxycycline administration. See also (Tumbar, 
Guasch et al. 2004; Waghmare, Bansal et al. 2008; Zhang, Cheong et al. 2009) for 
more details. 
 
Fluorescence Activated Cell Sorting 
To isolate different cell populations (bulge and non-bulge), mouse back and 
belly skin cells were isolated using trypsin digestion and filtered through 70-μm and 
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40-μm cell strainers (BD Biosciences) to obtain single-cell suspensions. Cells were 
labeled with CD34-Biotin (eBiosciences), Streptavidin-APC (BD Pharmingen), and 
anti–α6-integrin-PE (CD49f; BD Pharmingen). Propidium iodide (PI; Sigma) was 
used to label the dead cells. Bulge cells (CD34+/α6-integrin+) and nonbulge cells 
(CD34−/α6-integrin+) were isolated (Tani, Morris et al. 2000; Trempus, Morris et al. 
2003) for culture, RNA extraction, and H2B-GFP profile acquisition. BD 
fluorescence-activated cell sorting (FACS) Aria was used for cell sorting and BD 
LSRII was used for cell cycle analysis. Both machines were used to obtain H2B-GFP 
profiles from doxycycline (doxy)-chased mice at different stages. 
 
RNA Extraction, Quantitative Real-Time PCR, and Primer Sequences 
The RNeasy Micro kit (Qiagen) was used to extract RNA from FACS-isolated 
cells. All RNA samples were quality checked with Bioanalyzer (Bio-Rad) through the 
Cornell Life Sciences Core Laboratories Center. cDNA synthesis was carried out 
using the iScript (Bio-Rad) cDNA synthesis kit according to the manufacturer’s 
instruction. Quantitative real-time (q) PCR was carried out using homebrew SYBR 
Green PCR buffer. The iCycler (Bio-Rad) PCR machine was used to detect 
fluorescence. Primers used for qPCR are listed in Table 3.1. 
 
Chromatin Immunoprecipitation 
For Runx1 chromatin immunoprecipitation (ChIP) on p21 promoter, ∼0.5–1 × 
107 of wild-type (Runx1
fl/fl
) and inducible Runx1 knockout (iKO) (K14-CreERT2 x 
Runx1
fl/fl
) keratinocytes were treated with 4-OHT (4-Hydroxytamoxifen; Sigma-
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Aldrich) for 4 d before fixing. For Runx1 and p21 ChIP on p15 promoter, primary 
keratinocytes between passages three and seven, originally isolated from newborn skin, 
were used. All steps were carried out according to (Ortt and Sinha 2010) with minor 
variations. Cells were fixed for 3 min. Sonic Dismembrator model 100 (Fisher 
Scientific) was used to sonicate the chromatin. Protein A agarose beads (Millipore, 
#16-125) were used for immunoprecipitation. H3 (Abcam, #1791), Runx1 (Abcam, 
ab23980), p21 (Abcam, ab2961), H3K27me3 (Millipore, #07-449), and IgG 
(Imaginex or Cell Signaling) antibodies were used for immunoprecipitation. The PCR 
purification kit (Qiagen) was used to purify ChIP DNA. ChIP signals were calculated 
using ChIP-qPCR. Briefly, ChIP signals were interpolated from serial dilution of input 
DNA standards. Then, fold enrichment of (i) Runx1 signal over IgG (for Runx1 ChIP 
on p21 promoter) or (ii) WT Runx1 or p21 signals over respective double-(d)KO 
signals was compared at different regions of p21 or p15 promoters. Primers for ChIP-
qPCR are listed in Table 3.1. 
 
Cell Lines and Transfections 
For ChIP of H3K27me3 (Figure 3.2C), mouse keratinocytes between passages 
three and seven, originally isolated from newborn skin, were used (Osorio, Lilja et al. 
2011). Cells were either transfected with K14-Runx1-myc (epitope) or K14-eGFP-
myc (epitope) constructs using previously described method (Hoi, Lee et al. 2010), or 
overexpressed with inducible Runx1 transgene for 3hrs. Cells were fixed and 
harvested for ChIP analysis.  
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For CMV-p15-GFP transfection (Figure 3.9 D and E and Figure 3.8D), 
primary keratinocytes were isolated from newborn pups of WT, p21 KO, and 
Runx1/p21 dKO mice. At ∼70% confluency, 100 μL of serum-free medium 
containing a mixture of either 1 μg of CMVeGFP- myc (Osorio, Lilja et al. 2011) or 
CMV-p15-GFP (Origene) with 6 μL of Trans-Fectin lipid reagent (Bio-Rad) was 
added to the dishes. Cells were pulsed with BrdU and harvested between 24 and 30 h 
of incubation for cell cycle analysis, using the APC-BrdU Flow Kit (BD Biosciences) 
according to the manufacturer’s protocol. Cells were analyzed by BD-LSRII flow 
cytometry and gated specifically for transfected (GFP+) cells. 
For knockdown, 250 μL of serum-free media containing 12 μL of TransFectin 
lipid reagent and 4 μg of either p15-shRNA-GFP (Origene) or noneffective scrambled-
shRNA-GFP (Origene) were added to 50∼70% confluent WT, p21 KO, and 
Runx1/p21 dKO primary keratinocytes. Cells were harvested ∼72 h posttransfection 
and the cell cycle was profiled using the same approach as above. 
 
Immunofluorescence Staining, Paraffin Staining, Microscopy, and Image 
Processing  
Optimal Cutting Temperature compound-embedded frozen skin blocks were 
cryosectioned, fixed, immunoblocked, and incubated with antibodies. Antibodies and 
dilutions were BrdU (1:300; Abcam), Caspase-3 (1:500; R&D Systems), and CD34 
(1:150; BD Pharmingen). For paraffin staining, paraffin sections were deparaffinized 
in toluol, rehydrated with gradients of ethanol: 100%, 90%, and 70%. Antigen 
 78 
retrieval was carried out in either EDTA (Invitrogen) or citrate buffer (Invitrogen) by 
microwaving 10 min twice. Sections were blocked and incubated with antibodies. 
Antibodies and dilutions used were as follows: p21, 1:50 (Abcam); and K14, 1:2,000 
(Abcam). A fluorescence light microscope (Nikon) equipped with a charge-coupled 
device 12-bit digital camera (Retiga EXi; QImaging) was used to analyze all stained 
slides. 
 
Western Blot  
WT, p21 KO, Runx1 KO, and Runx1/p21 dKO mice were killed at PD21. 
Protein extracts were made via a previously described method (Osorio, Lee et al. 
2008). Anti-p15 (Abcam; 1:500) and anti-Actin (Millipore; 1:20,000) were used for 
immunoblotting. 
 
Computation and Mathematical Modeling 
 We infer the proportions of cells that have divided n times by a hierarchical 
Bayesian analysis that incorporates both the biological variations between mice, the 
experimental variations that broaden the FACS histograms into Gaussians, and the 
variations between the extents of H2B-GFP labeling in different mice. In addition, an 
enhanced method of variational Bayesian Gaussian mixture modeling (Attias 1999; 
Bishop 2006) is developed that can cope with noise in the low fluorescence region and 
identify peaks that are only partially resolved. This method may find applicability in 
FACS data analysis (Boedigheimer and Ferbas 2008) (Pyne, Hu et al. 2009) and a 
wide range of other onedimensional Gaussian mixture modeling problems as it 
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provides a Bayesian method for computing a combined posterior estimate from 
multiple mixture modeling analyses that systematically includes both intra- and 
intermixture variations (See detailed description in Figure 3.11). 
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Table 3.1. Primers for ChIP-qPCR / qPCR  
 
 
Application Gene/Region Forward Reverse 
ChIP-qPCR p21_01 TCACACCACAACAGACAAGGA TCAGGTCGTCAGGTTAGATGG 
ChIP-qPCR p21_02 CTCCTCCCACAAGGTCAAAC TCTTACCCACTGAGCCATCTC 
ChIP-qPCR p21_03 AGACCAGCAGCAAAATCGGA TTGGGTATCATCAGGTCTCCACC 
ChIP-qPCR p21_04 GCGGCTGTTTTTCTTGGTAG AGACGAGGAAAGCAGTTCCA 
ChIP-qPCR p21_05 GGGATTCCAGGTGCGGCTCG TCGGAGAACCGCTCTGCGCT 
ChIP-qPCR Gapdh ACCGAAGAACAACGAGGAGA GAGAACAGGGGAAATGGAGA 
 
ChIP-qPCR p15_01 ACTTCAGGATTACAACCAAAGC GGCGGTATTTCACAGTTAGCA 
ChIP-qPCR p15_02 GAAGGGGAGAAGCAAAGGAC CCAAATGAGGGAAAGAAATACAA 
ChIP-qPCR p15_03 GACTTTCTGTGCCTCTGTTCTCTA TGGGCTCAAGTTTGGAATATG 
ChIP-qPCR 
Wnt4_01 (neg)  
(Devgan, Mammucari et al. 2005) 
GTCTCAGCAGCAGGCTTACC TCAAATCCTGGATGCCAATC 
ChIP-qPCR 
Wnt4_02 (pos)  
(Devgan, Mammucari et al. 2005) 
CAATTCCCAGCACCAAAAGT TCCAAATAAGGTAGGTACCCAAAG 
qPCR p15 TCCACAGGCTAAATGGGAAA TCAGAATCCAGGCATCAAGG 
qPCR p16 GCCGCACCGGAATCCT TGCACCGTAGTTGAGCAGAAGA 
qPCR p18 AAAGATGGAACTGGTTTTGCTGT TGTGCTTCATAAGGAACTCCAC 
qPCR p19 GCCACTGTCTCCAGCCTTAC CCCCAAACACACACACTCAA 
qPCR p21 GTCCAATCCTGGTGATGTCC CAGACGAAGTTGCCCTCCA 
qPCR p27 TCTCTTCGGCCCGGTCAAT GGGGCTTATGATTCTGAAAGTCG 
qPCR p57 AGGGGAATGGTTGTTGAGTAA GGCAGTTGGTATGGGCAGT 
qPCR Bcl-2 TGGGATGCCTTTGTGGAACT ACAGCCAGGAGAAATCAAACAG 
qPCR Bcl-xl GGCTGGGACACTTTTGTGGAT GCGCTCCTGGCCTTTCC 
qPCR Mcl1 CCCTCCCCCATCCTAATCAG AGTAACAATGGAAAGCATGCCAAT 
qPCR Bim TTGGAGCTCTGCGGTCCTT CAGCGGAGGTGGTGTGAAT 
qPCR Puma GCGGCGGAGACAAGAAGA AGTCCCATGAAGAGATTGTACATGAC 
qPCR Bak AATGGCATCTGGACAAGGAC GTTCCTGCTGGTGGAGGTAA 
qPCR Bax TGGAGCTGCAGAGGATGATTG AGCTGCCACCCGGAAGA 
  
 81 
3.3 Introduction 
Tight regulation of quiescence likely maintains tissue stem cells (SCs) such as 
blood and hair follicle (HF) and may prevent cancer (Orford and Scadden 2008; Fuchs 
2009). Cyclin-dependent kinase inhibitors (CDKis) regulate the cell cycle in different 
tissue cell types. Some of the Cip/Kip (CDK interacting protein/kinase inhibitor 
protein) family [p21 (cyclin-dependent kinase inhibitor 1a, Cdkn1a), p27, and p57] 
and the Ink4 family (p15, p16, p18, and p19) of CDKis are known to prevent 
hematopoietic SC (HSC) exhaustion by limiting cell divisions (Matsumoto, Takeishi 
et al. 2011; Tesio and Trumpp 2011; Zou, Yoshihara et al. 2011), but their relevance 
in regulating other mammalian SCs in vivo is not well established. Some of the 
CDKis, such as p21, play different roles in HSCs in vivo vs. in stress conditions such 
as cell culture, transplantation, and carcinogenesis (Cheng, Rodrigues et al. 2000; van 
Os, Kamminga et al. 2007; Foudi, Hochedlinger et al. 2009; Viale, De Franco et al. 
2009; Matsumoto, Takeishi et al. 2011; Zou, Yoshihara et al. 2011). 
Interestingly, it has been recently suggested that cells may possess a sensing 
mechanism for the cellular level of total CDKis and that some CDKis act redundantly 
(Matsumoto, Takeishi et al. 2011; Tesio and Trumpp 2011; Zou, Yoshihara et al. 
2011). It is well known that in general CDKis are transcriptionally regulated (Orford 
and Scadden 2008; Tesio and Trumpp 2011) but the SC-specific transcriptional 
control and how it modulates adult SC behavior in vivo are not well understood. 
Because some SCs are apparently cycling frequently, it is also unclear how robust 
quiescence control actually is in vivo.  
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Here we use the mouse HF as a classical quiescent SC mammalian system 
(Cotsarelis 2006; Waghmare, Bansal et al. 2008) to examine transcriptional regulation 
and the role of CDKis, in an attempt to decipher the robustness of hair follicle stem 
cell (HFSC) cell cycle control in normal and stress conditions. HF adult homeostasis 
(hair cycle) is composed of distinct and synchronous phases of SC self-renewal, 
differentiation, and quiescence (Figure 3.1A) (Tumbar 2012). In each hair cycle upon 
activation from the quiescent (telogen) to the growth phase (anagen), a subset of bulge 
SCs migrate out into the hair germ below without self-renewal to differentiate and 
produce hair shafts (Zhang, Cheong et al. 2009). The remaining bulge cells self-renew 
at anagen and reenter quiescence at catagen when the matrix and the differentiated 
cells undergo apoptosis and the HFs return to quiescence (Tumbar 2012). 
Transcription factors such as NFATc1 (nuclear factor of activated T cells, 
cytoplasmic, calcineurin-dependent 1), Sox9 (SRY-box containing gene 9), Lhx2 
(LIM homeobox protein 2), and Runx1 (runt related transcription factor 1) (Tumbar 
2012) regulate the proliferation and maintenance of HFSCs during adult homeostasis. 
In particular Runx1, a transcription factor of the Runt family member of cancer genes 
(Speck and Gilliland 2002), promotes HFSC activation from quiescence to migrate, 
proliferate, and differentiate at telogen (Osorio, Lee et al. 2008) and self-renew at 
anagen (Hoi, Lee et al. 2010) and controls timely emergence of HFSCs and proper 
maturation during embryogenesis (Osorio, Lilja et al. 2011). Moreover, Runx1 is 
indispensable for skin tumorigenesis and for keratinocyte growth in culture. 
Interestingly, Runx1 deletion in mouse skin epithelium up-regulates p21 in the HFSCs 
(Hoi, Lee et al. 2010). p21 is a tumor supressor downstream of p53 known to arrest the 
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cell cycle in response to DNA damage and telomere shortening (Choudhury, Ju et al. 
2007). p21 knockout (KO) results in increased skin squamous papilloma in response to 
TPA (12-O-tetradecanoylphorbol-13-acetate)/DMBA (7,12-Dimethyl-benz(a)-
anthracene) (Topley, Okuyama et al. 1999), although it did not affect the progression 
to malignancy (Weinberg, Fernandez-Salas et al. 1999). Moreover, p21 KO mouse 
keratinocytes showed increased proliferation in vitro and enhanced short-term 
engraftment ability in vivo (Topley, Okuyama et al. 1999). Runx1 interacts genetically 
with p21 in cultured keratinocytes (Hoi, Lee et al. 2010), but the significance of this 
interaction in the normal tissue or in skin tumorigenesis is unknown. 
Here we document the transcriptional regulation of CDKis and their potential 
control by Runx1 in HFSCs.We use mouse genetics tools to concomitantly target 
Runx1 and p21 in vivo and examine their interplay in tumors, in cells in culture, and in 
the normal hair cycle. 
 
3.4 Results 
3.4.1 Regulation of CDKi expression during normal HFSC homeostasis 
To explore CDKis transcriptional control in HFSCs, we documented their 
mRNA expression profiles in CD34+/α6-integrin+ bulge cells isolated from mouse 
skin by fluorescence-activated cell sorting (FACS) at different hair cycle stages. We 
used HFs at proliferation (anagen) vs. quiescence (catagen/telogen) and performed 
quantitative real-time (q)PCR. First, p21 mRNA expression was up-regulated more 
than twofold in the WT quiescent vs. proliferative bulge (Figure 3.1B), in agreement  
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Figure 3.1. Regulation of p21 and other CDKis expression in normal HFSC 
homeostasis.  
 
(A) HFSC dynamics during normal skin homeostasis. (B) qPCR analysis of 
CDKi mRNAs in WT [telogen (PD20–21), anagen (PD24–27), and catagen (PD40–
42)] bulge (CD34+/α6+, Bu) and nonbulge (CD34−/α6+, NonBu) cells (Figure 3.2A) 
(C) Immuno-fluorescence staining of paraffin skin sections at anagen (PD27) and 
catagen (PD39) shows nuclear p21 (green) in quiescence (KO: p21KO). (D) ChIP-
qPCR with Runx1 antibody and primers to Gapdh and different regions of the p21 
promoter (Table 3.1, page 88) in WT and Runx1 inducible KO (iKO) keratinocytes 
(Figure 3.2 B and C). (E) Model for cell cycle control factors show inverse relation of 
p21 and other factors with Runx1 protein expression (red) (Osorio, Lee et al. 2008). 
(Two relative comparisons are independent). 
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with nuclear p21 protein signal in catagen/telogen bulge (Figure 3.1C). Nuclear p21 is 
known to inhibit cell proliferation (Zhou, Liao et al. 2001). Intriguingly, p57 and p27 
involved in HSC quiescence (Matsumoto, Takeishi et al. 2011; Zou, Yoshihara et al. 
2011), were up-regulated in the bulge relative to nonbulge (CD34−/α6+) at all hair 
cycle stages (Figure 3.1B), suggesting that they may be responsible for the overall low 
rates of bulge cell division (Waghmare, Bansal et al. 2008). Moreover, p57 and p15 
mRNAs were found at higher levels in the catagen and telogen bulge than in the 
anagen. p19 was equally expressed and p18 seemed to be more specific to the 
nonbulge cells, whereas p16 was undetectable in any of the cell fractions tested 
(Figure 3.1B). 
Next we wondered what regulates transcription of these CDKis throughout the 
hair cycle. We previously showed that Runx1 protein is expressed in the bulge during 
anagen and is at low levels at catagen and telogen when HFSCs are quiescent (Osorio, 
Lee et al. 2008). This suggested an inverse correlation of Runx1 protein and CDKi 
mRNA level in the bulge throughout the hair cycle, making Runx1 a potential 
repressor of CDKis (Figure 3.1E). Indeed, p21 was up-regulated in the bulge when we 
previously deleted Runx1 at anagen (Hoi, Lee et al. 2010). Here we isolated 
CD34+/α6+ bulge cells from Runx1 KO mice at quiescence [postnatal day (PD) 21] 
before the onset of the Runx1 phenotype. We observed not only p21, but also p27 
(three of three mice) and p57 (two of three mice showed increased expression whereas 
one showed a similar level compared with WT) mRNAs up-regulated in the Runx1 
KO (CD34+/α6+) cells relative to WT (see Figure 3.9A). This was consistent with the  
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Figure 3.2. Runx1 directly represses p21 promoter and the p21 knockout bulge cells 
proliferate more in vitro and in vivo.  
 
(A) FACS plots of bulge and nonbulge skin cell isolation. Single cells freshly 
isolated from mouse skin were stained and immediately FACS sorted. Gating order is 
cells → singlets → live cells (PI negative) → bulge cells, α6-integrin+ (PE)/CD34+ 
(APC); nonbulge cells, PE+/APC−. (B and C) ChIP-qPCR with H3K27me3, H3, and 
IgG antibodies on p21 promoter upon Runx1 overexpression (Materials and Methods). 
Note the increased H3K27me3 on p21 promoter upon Runx1 overexpression. (D) 
Representative cell cycle plot of BrdU-APC and 7-AAD in p21 WT and KO. (E) 
Representative H2B-GFP FACS histograms of PD21–47 doxy-chased bulge cells. (F) 
Microscopy quantification of H2B-GFP fluorescence in bulge cells. 
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prolonged quiescence of HFSCs in the Runx1 KO and suggested that Runx1 acts as a 
repressor for several CDKis in vivo. 
Loss of Runx1 in cell culture induced a severe proliferation defect and p21 loss 
rescued this phenotype (Hoi, Lee et al. 2010), suggesting an important genetic 
interaction between Runx1 and p21 in vitro. To ask whether this interaction works by 
the direct binding of Runx1 to the p21 promoter, which Runx1 may inhibit, we 
performed chromatin immunoprecipitation (ChIP) on mouse keratinocytes. This 
revealed enrichment of Runx1 at a conserved Runx1 binding site in the p21 genetic 
locus (p21_05) relative to other regions [p21_01-04 and Gapdh (glyceraldehyde-3-
phosphate dehydrogenase)] and relative to Runx1 inducible KO cells (Figure 3.1D). In 
addition, the p21 promoter was enriched with a repressive histone mark, H3K27me3 
upon Runx1 overexpression (Figure 3.2 B and C), likely via recruitment of 
corepressors of the Polycomb group proteins (Yu, Mazor et al. 2012). In conclusion, a 
number of CDKis, including p21, p27, p57, and p15, are expressed and/or up-
regulated at the mRNA level in the bulge at quiescence. Their redundant presence 
likely contributes to overall bulge cell quiescence and timely cell cycle exit in catagen. 
Moreover, p21 is likely a direct downstream repressional target of Runx1 and 
downregulation of Runx1 protein in the bulge could result in the up-regulation of p21, 
followed by cell cycle exit at catagen. 
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3.4.2 P21 reduces proliferation of HFSCs in vitro and controls their timely exit 
into quiescence in vivo 
The role of p21 in HFSCs in vivo has not been yet analyzed. p21 KO mice are 
viable and fertile and have roughly normal appearance. To understand the role of p21 
in HFSCs, we analyzed the proliferation ability of bulge (CD34+/α6+) HFSCs from 
WT and p21 KO cultured cells (Figure 3.3A and Figure 3.2D). This revealed increased 
S and G2/M phase with a concomitant decrease of G0/G1 p21 KO cells, suggesting 
that p21 indeed plays a role in bulge cell proliferation in vitro, as we expected from its 
role in keratinocytes (Topley, Okuyama et al. 1999). 
To understand whether p21 loss affects bulge cell proliferation and skin 
homeostasis in vivo we used our previously developed H2B-GFP tet-repressible pulse-
chase system (Tumbar, Guasch et al. 2004; Waghmare, Bansal et al. 2008). 
Doxycycline (doxy) shuts down H2B-GFP expression and results in dilution of the 
label at each division by twofold. We performed doxy “chases” on mice from PD21 to 
PD47 to span the first adult hair cycle (Figure 3.3B), killed the mice, and examined 
CD34+/α6+ bulge cell divisions by FACS (Figure 3.3C and Figure 3.2E). A 
computational method was devised to delineate individual peaks of H2B-GFP 
fluorescence (FL) from FACS (Figure 3.3C and Figure 3.4A). This quantification 
revealed that p21 KO bulge cells divided more than WT during one normal hair cycle, 
as seen in the increased cell fraction with lower H2B-GFP FL (Figure 3.3 C and D). In 
addition, the bright H2B-GFP label-retaining cells (LRCs), which were previously 
deemed a population of relatively unused “reserve” SCs (Hsu, Pasolli et al. 2011), 
were also induced to replicate by the p21 KO (Figure 3.3E and Figure 3.2F). However,  
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Figure 3.3. p21 represses bulge cell proliferation in vitro and in vivo and regulates 
timely cell cycle exit.  
 
(A) CD34+/α6+ sorted cells cultured and BrdU pulsed for 30 min were labeled with 
anti–BrdU-APC and 7-AAD, and the cell cycle was profiled using a FACS analyzer 
(at least two mice per condition, n = 3 experiments). (B) Doxy chase schemes 
followed by BrdU injection 2 h before mice were killed. (C) Individual H2B-GFP 
peak modeling of PD21–47 bulge cell FACS data (Figures 3.2E and 3.4A and 
Materials and Methods). (D) Quantification of the fraction of labeled bulge cells under 
each peak from C. (E) Representative HF image of PD21–47 doxy-chased bulge cells 
stained with CD34. (F and G) PD21–47 WT (F) and KO (G) H2B-GFP FACS data 
fitted with a homogeneous population Poisson model (Figure 3.4B and Materials and 
Methods). Note KO data are not fitted. Error bars show the 1σ credible intervals (data) 
or the predicted proportions corresponding to the 1σ intervals of the best-fit replication 
rates (model). (H–J) Fraction of labeled bulge cells from different doxy “chased” mice. 
(K) Quantification of percentage of BrdU+ bulges (gray) and percentage of caspase-
3+ bulges (black) in skin sections from mice at age or stage indicated. Two to three 
mice per genotype and 30–300 HFs per mouse were analyzed. 
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by PD47, WT and p21 KO mice showed a similar fraction (3–4%) of BrdU+ bulges, 
suggesting that the majority of HFs of both types reentered quiescence (Figure 3.3K, 
PD47). Interestingly, all CDKi levels remained unchanged in p21 KO, suggesting that 
enough CDKis may be already expressed in the bulge to maintain bulge cell 
quiescence even in the absence of p21 (Figure 3.5F). 
A simple Poisson model fitted the WT experimental data (Figure 3.3F) 
(Materials and Methods) and indicated approximately three divisions per bulge cell in 
one hair cycle, as we previously reported (Waghmare, Bansal et al. 2008). Intriguingly, 
this model did not fit the KO experimental data indicating that the bulge cells do not 
have a homogeneous response to p21 KO (Figure 3.3G and Materials and Methods). A 
mathematical model assuming that only a subpopulation of the bulge cells respond to 
p21 loss does fit the data (Figure 3.4B) and suggests that ∼40% of the KO bulge cells 
present at PD47 had replicated at least three times more than WT. Collectively, p21 
KO bulge cells divide more in vitro and in vivo. Extra divisions affect even the most 
quiescent bulge cells, but all cells eventually return to quiescence. 
To see whether p21 regulates rates of proliferation or timely cell cycle exit 
during quiescence, we performed short doxy chases at anagen and catagen (Figure 
3.3B). Bulge cells self-renew symmetrically at anagen to replenish their pool depleted 
by migration in the preceding phase (Zhang, Cheong et al. 2009; Zhang, White et al. 
2010). Analysis of sorted bulge cells showed comparable numbers of bulge cell 
divisions in WT and p21 KO skin during PD24–27 (rapid self-renewal phase) (Figure 
3.3H and Figure 3.5A) with no significant differences in BrdU+ bulges at PD27 
(Figure 3.3K), suggesting that p21 did not affect the rates of self-renewal in early  
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Figure 3.4. Statistical and theoretical analysis.  
 
(A) Quantification of the proportion of cells within each H2B-GFP peak by variational 
Bayes Gaussian mixture modeling. (B) Best fit model of the PD21–47 KO data using 
the two-population Poisson model. The error bars show the standard deviations of the 
predicted proportions. See Materials and Methods for details. 
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anagen. However, by PD35, which marks the beginning of catagen when bulge cells 
return to quiescence, increased growth of ∼9% (as estimated by mathematical 
modeling) of p21 KO bulge cells could be detected from FACS and BrdU data at 
PD35 (Figure 3.3 I and K and Figure 3.5 B and D). This increase in p21 KO bulge cell 
proliferation was more pronounced by PD42 as seen in additional divisions clearly 
detected in the PD36–42 chase (Figure 3.3J and Figure 3.5C). Our mathematical 
modeling indicated that the WT bulge cells reduced their division rates by sevenfold in 
catagen compared with anagen (Figure 3.11), but that the reduction for KO cells was 
roughly half as much. Both WT and KO bulge cells eventually entered quiescence by 
telogen as shown by BrdU staining (Figure 3.3K, PD47). In summary, whereas WT 
bulge cells divided approximately three times in anagen and had greatly reduced 
proliferation after catagen onset, p21 KO bulge cells overall divided approximately 
one to two more times before entering quiescence, reflecting the existence of a cell 
fraction with a higher replication rate and/or extended replication period. 
Interestingly, the extra bulge cells generated by prolonged proliferation due to 
p21 loss did not increase the bulge cell pool (Figure 3.3E and Figure 3.6A) measured 
by number of CD34+ cells per bulge at second telogen. This is, at least in part, 
explained by a KO-correlated increase in apoptosis in early catagen. Levels of 
apoptotic caspase-3+ cells in the p21 KO bulge showed an approximately threefold 
increase at PD35, the stage when we also detected failure of p21 KO cells to enter 
quiescence (Figure 3.3K and Figure 3.5E). This was consistent with the known anti-  
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Figure 3.5. p21 loss delays the onset of bulge cell quiescence in normal homeostasis.  
 
(A–C) Individual H2B-GFP peak modeling of PD24–27, PD21–35, and PD36–42 
doxy-chased bulge cells FACS data. Note in C that p21 KO bulge cells fail to enter 
quiescence in a timely manner and undergo additional divisions. (D and E) 
Representative hair follicle (HF) images of immunofluorescent-labeled skin sections 
for BrdU (D) and Caspase-3 (E). Arrowhead indicates a positive cell. (F) Ratio of fold 
mRNA qPCR enrichment of p21 KO over WT at PD42 shows insignificant changes. 
At least two mice per genotype were used. 
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Figure 3.6. p21 knockout bulge cell pool size is maintained constant by increased 
apoptosis.  
 
(A) Quantification in immunofluorescently labeled skin sections of CD34+ cells per 
bulge in p21 WT and KO at second telogen. Note the bulge cell pool size did not 
increase in the KO. (B) qPCR analysis of apoptotic genes at PD42. At least two 
different mice were used per genotype. Note the significant differences in expression 
between WT and p21 KO (black lines). 
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apoptotic role of p21 (Suzuki, Tsutomi et al. 1998). Moreover, catagen bulge up-
regulated not only pro- but also anti-apoptotic genes (Willis, Day et al. 2003), likely to 
protect against excessive bulge cell death upon p21 loss (Figure 3.6B). Finally, we did 
not observe colocalization of BrdU+ and caspase-3+ bulge cells, ruling out the 
possibility that p21 KO bulge cells die as they enter the cell cycle at an unpermitted 
time. Thus, it appears that some p21 KO bulge cells die to compensate for prolonged 
proliferation and to keep the bulge cell pool size constant. In conclusion, we found 
that p21 is important for regulating general rates of HFSCs in vitro whereas in vivo its 
up-regulation at quiescence, likely driven by down-regulation of Runx1 protein in the 
bulge, limits the extent of HFSC divisions during homeostasis. 
 
3.4.3 Runx1/p21 genetic interaction is context dependent 
Although p21 KO rescued the proliferation phenotype of keratinoyctes in 
culture (Hoi, Lee et al. 2010), it was unclear whether Runx1-driven effects on the cell 
cycle in vivo or in tumors were mediated by p21. To ask whether prolonged HFSC 
quiescence in Runx1 single-KO mice is mediated via de-repression of p21, we 
generated Runx1/p21 double-KO (dKO) mice and examined the proliferation onset by 
skin color change (pink to black). Unexpectedly, HFSCs in the dKO mice not only 
failed to overcome the prolonged quiescence imposed by Runx1 loss as we predicted, 
but in fact remained in telogen much longer (Figure 3.7A–C, Figure 3.10A). These in 
vivo data contrasted strikingly with our previous in vitro study (Hoi, Lee et al. 2010) 
and indicated that in vivo but not in vitro, double KO of a CDKi (p21) and its 
upstream repressor (Runx1) triggered deep repression of the bulge cell proliferation.  
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Figure 3.7. Runx1–p21 interaction plays context-dependent roles in regulating 
proliferation.  
 
(A) Skin coat color at PD35 indicates different hair cycle stages: Single p21 and 
Runx1 KO mice were in anagen (black); dKO was in telogen (pink). (B) Summary of 
mice and color coding used for data in C–F. (C) Anagen onset is delayed in Runx1 KO 
and much further delayed in dKO mice (p<0.001, Log-Rank and Wilcoxon tests) (D) 
(Upper) Two-step carcinogenesis scheme (Materials and Methods); (Lower) 
Representative mouse pictures at 15 wk TPA treatment. Treatment began upon second 
telogen onset in all mice. (E) Number of papillomas over time with t-test statistical 
analysis. Note: additional statistical test using standard least square regression (shown 
in Figure 3.10) revealed no statistical differences between Runx1 KO and dKO during 
the entire 20 weeks (p=0.3506) (dKO vs p21 KO, p=0.0004; dKO vs WT, p=0.0006). 
However, between weeks 13-16, Runx1 KO and dKO mice showed a significant 
difference (p=0.0229) (F) Fraction of papilloma-bearing mice (statistical analyses for 
E and F also in Figure 3.8 A and B). (dKO vs WT p=0.00628; dKO vs p21KO 
p=0.0325; dKO vs Runx1KO p=0.0631). 
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To examine the effect of Runx1 and p21 interaction in tumors we used a two-
step carcinogenesis protocol, using DMBA/TPA on single- and double-Runx1/p21 KO 
mice (Figure 3.7D). This generates skin tumors that eventually progress to squamous 
cell carcinoma (SCC) (Kemp 2005). At least some of these SCCs were previously 
shown to originate from bulge SCs (Lapouge, Youssef et al. 2011; White, Tran et al. 
2011; Scheitz, Lee et al. 2012). Because carcinogenic treatment can produce different 
amounts of tumors on different genetic backgrounds (Hennings, Glick et al. 1993), we 
controlled the mating scheme to generate four different genotypes with a fixed ratio of 
BL6 and CD1 backgrounds for the final experimental mice. This may be responsible 
for the high error bars that did not allow us to detect significant tumor differences 
between WT and p21 KO mice, as previously reported (Topley, Okuyama et al. 1999; 
Weinberg, Fernandez-Salas et al. 1999). Upon DMBA/TPA treatment initiated at the 
second telogen, Runx1 KO mice, however, had significantly (P < 0.05, weeks 11–20) 
fewer papillomas compared with WT, as expected. At 15–16 wk of TPA treatment, the 
dKO mice had significantly more tumors than the Runx1 KO (P < 0.05) but fewer than 
WT and p21 KO mice (Figure 3.7 D–F, Figure 3.10 B), suggesting a partial rescue of 
the tumor impairment phenotype imposed by the Runx1 KO. However, by the 20th 
week of TPA treatment the differences in tumor burden or fraction of tumor-free mice 
were not statistically different from those of the Runx1 single-KO mice. These results 
suggest that p21 repression via Runx1 plays a minor role in promoting skin papillomas 
and that additional Runx1 targets must be at play for full tumor cell growth in vivo. In 
conclusion, we found three different responses of skin epithelial cells to concomitant  
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Figure 3.8. Context-dependent control of hair follicle stem cells (HFSCs) by Runx1–
p21 interplay.  
 
(A and B) Statistical analysis of Runx1/p21 mice: (A) Kaplan–Meier survival test for 
Figure 3.7F and (B) Student’s t test for Figure 3.7E. (C) qPCR of control genes 
[Runx1, p21, and Keratin14 (epithelial-specific)] on cultured cells. (D) Cell cycle 
analysis of WT and dKO cells harvested 24 h after transfection with CMV-eGFP-myc 
or CMV-p15-GFP (details in Materials and Methods). A representative cell cycle 
histogram of dKO with or without p15-GFP transfection is shown. (E) p15 
knockdown of dKO keratinocytes via transfection of p15shRNA-GFP or scrambled-
shRNA-GFP (control) followed by cell cycle analysis. (Left) Selection of transfected 
cells (FITC+); (Right) representative dKO cell cycle histogram of p15-shRNA (red) 
and scrambled-shRNA (blue). 
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loss of Runx1 and p21. When in cell culture keratinocytes proliferate nearly as WT 
cells (Hoi, Lee et al. 2010), when in tumors they proliferate more than Runx1 single-
KO cells but not as well as the WT cells, whereas when in their intact niche (bulge) 
HFSCs became even more profoundly quiescent upon concomitant Runx1/p21 loss. 
 
3.4.4 Runx1-p21 interplay synergistically up-regulates p15 
Next, we examined the discrepancy in Runx1–p21 interplay on epithelial cells 
found in normal tissue conditions or in cell culture. We hypothesized that the 
prolonged HFSC quiescence in vivo might be due to compensation by redundant 
CDKis up-regulated upon concomitant Runx1/p21 loss. Thus, we analyzed CDKi 
mRNA expression in bulge (CD34+/α6+) cells from telogen mice of all four 
genotypes (Figure 3.9A). Interestingly, dKO bulge cells showed an approximately 
fivefold increase in p15 expression whereas none of the single-KO or the nonbulge 
cells showed p15 up-regulation in vivo. Moreover, this increase in p15 was also 
detected at the protein level (Figure 3.9C). Interestingly, we noted that p27 and p57, 
which were somewhat up-regulated in the single Runx1 KO, were expressed at normal 
levels in dKO bulge cells (Figure 3.9A) (Discussion). 
Because, unlike dKO bulge cells in vivo, which remain profoundly quiescent, 
the dKO cells grow normally in culture (Hoi, Lee et al. 2010), we hypothesized that 
p15 up-regulation might not occur in vitro. Indeed, dKO cells grown at log phase (<70% 
confluency) did not significantly up-regulate any of the CDKis mRNA compared with 
p21 KO and WT cells (Figure 3.9B, gray, Figure 3.8C for control genes). However, 
we observed that cells grown at over 70% confluency, conditions that may better  
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Figure 3.9. Runx1–p21 interaction involves synergistic p15 repression.  
 
(A) Bulge (black) and nonbulge (gray) qPCR signal of all CDKis in vivo in telogen 
(PD21) (n ≥ 3 mice, n = 3 independent experiments). (B) qPCR analysis of CDKis in 
cell culture (n = 2 independent cell lines, n = 3 experiments). Note the significant p15 
up-regulation in >70% confluency dKO (Figure 3.8C). (C) (Upper) Representative 
Western blot of p15 from total skin protein extracts at first telogen; (Lower) p15 
protein level normalized to actin. n = 3 independent experiments. (D and E) Cell cycle 
analysis of WT and dKO cells harvested 24 h after transfection with CMV-eGFP-myc 
or CMVp15-GFP. A representative cell cycle histogram of GFP+ (transfected) cells is 
shown in D and the quantification is in E (Figure 3.8D). (F) Increase in percentage of 
S/G2/M-phase cells upon p15 shRNA knockdown over scrambled control is shown. 
WT and dKO keratinocytes were harvested 72 h after transfection and the GFP+ cells 
were FACS analyzed (Figure 3.8E). (G and H) Runx1 and p21 ChIPs show direct 
binding of Runx1 and p21 on p15 promoter in keratinocytes. Gapdh and P21_05 are 
the same regions shown in Figure 3.1D. Wnt4_01 (neg) and Wnt4_02 (pos) regions 
were previously shown to bind p21 (Devgan, Mammucari et al. 2005) (n = 3 
independent experiments). (I) Molecular pathway of Runx1/p21-mediated HFSC 
proliferation regulation. Direct (red) and potentially direct (question mark) regulatory 
mechanisms revealed from this study are shown. 
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resemble the crowded bulge cells in their niche, in fact up-regulated p15 (Figure 3.9B, 
black). 
To test whether p15 alone could block the proliferation of cycling cells in log-
phase cultures, we transfected keratinocytes with p15-GFP cDNA and examined the 
cell cycle profiles relative to those of nontransfected and GFP-myc control transfected 
cells by FACS. Gating on the GFP+ (transfected) cells showed >50% reduction in 
S/G2/M phases in both WT and dKO keratinocytes with a concomitant increase in 
G0/G1 induced by p15 overexpression (Figure 3.9D and E and Figure 3.8D). On the 
other hand, shRNA knockdown of p15 showed increased proliferation, which was 
more prominent in dKO than in WT keratinocytes (Figure 3.9F and Figure 3.8E). 
Finally, to explore how Runx1 and p21 may synergistically repress p15 transcription, 
we examined their direct binding on the p15 promoter region. p21 was previously 
shown to bind to E2F binding sites and repress downstream transcription on the Wnt4 
(wingless-related MMTV integration site 4) promoter (Devgan, Mammucari et al. 
2005). Importantly, we found that Runx1 and p21 both bind to p15 promoter regions 
at their own respective binding motifs (Figure 3.9 G and H), suggesting that they may 
directly repress p15 transcription. 
 
3.5 Discussions 
Here we probed the mechanism of HFSC quiescence in normal tissue and in 
stress conditions of tumors and cell culture.We found several CDKis (p21, p57, p27, 
and p15), known to play overlapping roles in halting the cell cycle (Matsumoto, 
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Takeishi et al. 2011; Tesio and Trumpp 2011) transcriptionally up-regulated either in 
the bulge at all stages or at the onset of HF quiescence. Using pulse-chase H2B-GFP 
mice (Waghmare, Bansal et al. 2008) we find that p21 represses HFSC rates of 
proliferation in vitro and limits the HFSC extent of proliferation at catagen onset in 
vivo, but does not affect HFSC self-renewal rates at anagen. Overall p21 KO bulge 
cells undergo approximately one to two more divisions at catagen, but increased 
apoptosis maintains the bulge cell pool at a constant size. Mathematical modeling 
suggests a temporary escape from quiescence in a fraction of the KO bulge cells 
(Materials and Methods). Interestingly, loss of Dacapo, the Drosophila p21 homolog, 
also leads to an additional round of cell division before developmental arrest (de 
Nooij, Letendre et al. 1996). The p21 KO bulge cells eventually enter quiescence 
likely via concerted action of other bulge up-regulated CDKis (p27, p57, and p15). 
One of the upstream players in the mechanism of CDKi control in vivo appears 
to be the transcription factor Runx1, which may repress p21, p27, p15, and p57 
mRNA production and is directly bound to the p21 promoter where it promotes 
H3K27me3 accumulation. We propose that p21 (and possibly p57) derepression due 
to down-regulation of the Runx1 protein at catagen promotes the timely onset of WT 
HFSC quiescence and limits the expansion of their pool (this work). Conversely, 
Runx1 protein expression in the bulge at anagen represses p21 expression and 
promotes self-renewal (Hoi, Lee et al. 2010). 
The Runx1/p21 dKO mice display a surprising extension of HFSC quiescence 
in vivo, whereas keratinocytes in culture grow normally (Hoi, Lee et al. 2010). Tumors 
showed an intermediate effect, suggesting that additional Runx1 targets, of which 
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Stat3 is an important player (Scheitz, Lee et al. 2012), are at play to promote tumor 
growth. These data exposed a robust SC control in vivo that seemingly limits the 
normal SC pool size and enforces quiescence. A potential factor in this mechanism is 
another CDKi, p15, which is up-regulated specifically in the bulge only in the 
Runx1/p21 dKO mice. Our data suggest that when cultured cells are crowded, 
transcriptional up-regulation of this CDKi (p15) is driven by direct synergistic 
derepression of its promoter via loss of p21 and Runx1. Previously, p21 and Runx1 
were shown capable of acting as transcriptional repressors (Speck and Gilliland 2002; 
Devgan, Mammucari et al. 2005; Ferrandiz, Caraballo et al. 2012; Marques-Torrejon, 
Porlan et al. 2012), and we find that they bind to the predicted DNA sites on the p15 
promoter. Additionally, p15 expression is able to hamper cell cycle progression of 
cultured keratinocytes. These data reveal the case of one CDKi as a direct 
transcriptional repressor of another, to finely tune the extent of quiescence (Figure 
3.9I). 
Because SCs in tissues need not only to be quiescent to protect their genome, 
but also to activate rapidly when needed, it may be that high steady-state levels of 
CDKis are undesirable. An intriguing mechanism to keep CDKi levels in check may 
involve the dual role of some CDKis as CDK inhibitor and transcriptional repressors. 
Recently p27 was also shown to repress transcription, although direct targeting by p27 
of another CDKi did not surface from this study (Pippa, Espinosa et al. 2011). It will 
be interesting to know how general is the ability of one CDKi to directly repress 
another, such that when one is inadvertently lost, another is up-regulated to maintain 
proliferation control. For example, if p15 could repress p27 and p57, this would 
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explain why the latter two were not expressed in the context of the Runx1/p21 dKO 
when the level of p15 was high. Clearly there is more to learn about CDKis beyond 
their traditional function in CDK inhibition. Testing triple-KO p21/Runx1/p15 mice 
will begin to address this model in vivo, although additional control layers may further 
enforce quiescence and possibly complicate the analysis. 
Collectively, our study uncovers a complex and robust mechanism in vivo that 
enforces SC quiescence and a constant SC pool size and is synergistically tempered by 
Runx1 and, unexpectedly, by its downstream CDKi target (p21). Moreover, we unveil 
a role of a CDKis (p21) to antagonize proliferation by direct transcriptional repression 
of another CDKi (p15) in vitro, thereby modulating the strength of cell cycle arrest. 
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Figure 3.10. Additional statistical analyses of Runx1/p21 interactions.  
 
(A) Statistical analysis of anagen delay in Runx1/p21 double knockout shown in 
Figure 3.7C using survival test. Note both Log-Rank and Wilcoxon test show 
p<0.0001 (B) Additional statistical analysis of number of papillomas over time in 
Runx1/p21 mice shown in Figure 3.7E using standard least square regression approach. 
Comparison of Runx1 KO and dKO mice during 20 weeks duration showed no 
significant difference (p=0.3506). However, the difference was significant (p=0.0229) 
between weeks 13-16. All other comparisons showed significant differences (dKO vs 
p21 KO: p=0.0004; dKO vs WT: p=0.0006).  
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Figure 3.11. Statistical and Theoretical Methods 
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CHAPTER 4  
HAIR FOLLICLE STEM CELL QUIESCENCE IS ASSOCIATED WITH 
LOW LEVELS OF HISTONE H3K9ME3, H3K27ME3, AND H3K4ME3 
MARKS AND HIGH GENOME PLASTICITY MEDIATED BY GROWTH 
FACTOR SIGNALING
3
 
 
 
 
4.1 Introduction 
Stem cells play a crucial role in maintaining adult tissues by giving rise to 
progenitors that further differentiate and form functional structures during homeostasis 
as well as injury. Loss of proper self-renewal and/or differentiation abilities of tissue 
stem cells may lead to failure of tissue maintenance, or may lead to cancer (Fuchs 
2009; Daley 2012). Thus, understanding the molecular basis of how tissue stem cells 
balance between proliferation and quiescence, as well as how they control their fate to 
self-renew or differentiate, is of great importance in advancing stem cell biology and 
its applications to medicine.  
Chromatin regulation has recently been shown to play crucial roles in stem cell 
biology (Orkin and Hochedlinger 2011). Embryonic stem cells possess hyperdynamic 
chromatin characteristic (Meshorer, Yellajoshula et al. 2006) along with overall low 
                                                 
3
 This chapter has not yet been published. Author contributions: K.C.Lilja assisted in experiments in 
Figure 4.2H-I and 4.6A; K.J.Colletier assisted in experiments in Figure 4.2H-I and 4.6B-D; L.Yao 
initiated and generated preliminary data for Figure 4.8A-E; L.Tu performed experiments and analyzed 
data for Figure 4.8F-K; C.S.Scheitz assisted in developing the quantitative ChIP-seq data analysis; 
J.Lee performed and analyzed all other experiments; J.Lee assembled all figures and wrote the first 
draft; J.Lee and T.Tumbar designed the research.  
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level of repressive histone modifications (Hawkins, Hon et al. 2010). Moreover, 
histone modifying enzymes act as a mediator of reprogramming (Onder, Kara et al. 
2012) and repressive histone marks can act as a barrier during the reprogramming 
process (Chen, Liu et al. 2013). These suggest that global characteristics of histone 
modifications may influence embryonic stem cell genome plasticity, which become 
more restricted upon lineage commitment. However, whether similar processes take 
place in tissue stem cells as well as what regulates their global histone modification 
status remains unclear.  
Hair follicle stem cells reside in a specialized niche called the bulge and 
undergo cyclic phases of proliferation and quiescence, which results in cycles of hair 
growth and regression respectively (Tumbar 2012). Prior to self-renewal some bulge 
cells migrate out from their niche in quiescence and become progenitors that further 
proliferate and differentiate into different lineages of hair follicle (Zhang, Cheong et al. 
2009) (Figure 4.1). Later during the hair proliferative stage (anagen), bulge cells self-
renew to make up for the loss. How these processes may be regulated via epigenetic 
mechanisms require further exploration. 
Here we use mouse hair follicle as a model system to address the role of 
epigenetic regulation in balancing between proliferation and quiescence, as well as in 
fate determination. We show that multiple growth factors directly regulate the 
transcription of histone modifying enzymes, which bring about the globally low status 
of active (H3K4me3) and repressive (H3K9me3/H3K27me3) histone methylations, 
predisposing hair follicle stem cell genome into a plastic state. Coincidentally, the 
quiescent phase is the time of cell fate decisions in the hair follicle stem cells, where 
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one of two possible fates is chosen: (1) to migrate away from the niche, rapidly 
proliferate, terminally differentiate and eventually die by apoptosis, or (2) to remain as 
a stem cell in the niche and divide symmetrically to make more stem cells. We 
propose a model in which a robust epigenetic mechanism that controls histone 
methylation at specific marks couples quiescence and fate determination during 
normal tissue homeostasis.   
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Figure 4.1. Hair follicle stem cells during quiescence and fate determination. 
 
Hair follicle stem cells enter quiescence in catagen. During quiescence, a few hair 
follicle stem cells migrate out from the native niche (bulge) and acquire progenitor cell 
fate. Later during the anagen, remaining cells in the bulge self-renew to replenish the 
stem cell pool (Zhang, Cheong et al. 2009). Image adopted and modified from (Lee 
and Tumbar 2012). 
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4.2 Materials and Methods 
Mice, Growth factor-beads injections 
All mice were treated according to Cornell University Institutional Animal 
Care and Use Committee protocols. We used CD1 x FVB wild-type strain for our 
analysis including histone methylation characterization and ChIP-seq. To induce 
reprogramming, we crossed K14-rtTA (from E. Fuchs, Rockefeller University, New 
York, NY) with Col1a1-tetO-Pou5f1-Sox2-Klf4-Myc (Jackson Laboratories 
B6;129S4-Col1a1
tm1(tetO-Pou5f1,-Klf4,-Sox2,-Myc)Hoch
/J, #011001). For delivery of growth 
factor-coated beads, we used an approach previously described (Plikus, Mayer et al. 
2008; Greco, Chen et al. 2009; Oshimori and Fuchs 2012). A small region of the 
mouse back skin was shaved. Recombinant mouse Noggin (R&D systems) was 
injected intradermally with FluoSpheres (Invitrogen) for 5 consecutive days on the 
same region. BrdU administration was done either intraperitoneally in PBS or via 
drinking water bottle (25μg/g). 
 
Cell culture  
For growth factor removal, mixed strain (129 x BL6) of wild-type newborn 
mouse skin was used to derive primary keratinocytes, which were expanded and used 
for experiments (between passages 4-6) (Osorio, Lilja et al. 2011). Cells were first 
grown to confluency. Then cells were washed once with PBS and added serum-free 
media containing either recombinant BMP4 (R&D systems) or its carrier only. Cells 
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incubated for 2, 4, 6, 8, 10, and 12 hours were harvested for RNA and histone protein 
extractions.  
For fluorescence recovery after photobleaching (FRAP), primary keratinocytes 
were derived from K5-rtTA x pTRE-H2BGFP. Keratinocytes were treated with 
Doxycycline 2ug/mL for at least 48hrs to induce H2BGFP expression. Cells cultured 
in low Calcium media (0.05mM) were proliferating cells. Proliferating cells were 
treated with doxycycline for two days. Treatment with high Calcium (2mM) for 48hrs 
leads to keratinocyte differentiation. However, doxycycline induction is less efficient 
(fewer cells expressing H2B-GFP) under differentiation condition than cells under 
normal growth (potentially due to stratification). Therefore, cells were pre-treated with 
doxycycline for one day under low Calcium prior to two days incubation in high 
Calcium media. To keep cells in quiescent state, cells were starved by serial media 
dilution over three days (day 1: 50% of normal serum; day 2: 50% of normal serum; 
day 3: 25% of normal serum). Doxycycline was induced on the second day.  
 
Immunofluorescence staining 
Antibodies and dilutions used for staining are H3K4me3 (1:500; ActiveMotif), 
H3K9me3 (1:500; Millipore and Abcam), H3K27me3 (1:500-1:1000; Millipore), 
BrdU (1:300; Abcam), CD34 (1:150; BD Pharmingen). Protocol for staining have 
been previously described (Lee, Hoi et al. 2013). A fluorescence light microscope 
(Nikon) equipped with a charge-coupled device 12-bit digital camera (Retiga EXi; 
QImaging) was used to analyze all stained slides. 
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Western blot 
For histone protein detection we FACS-isolated bulge and non-bulge cells. To 
extract histone proteins, cells were first incubated in Triton Extraction Buffer (PBS 
containing 0.5% Triton X 100 (v/v), 2mM phenylmethylsulfonyl fluoride), followed 
by 0.2N HCl incubation. H3K9me3 (1:500 – 1: 3000; Millipore) and H3 (1:3000 – 1: 
10,000; Abcam) was used for immuoblotting. 
 
Quantitative real-time PCR 
A previously described method was used for RNA extraction and quantitative 
real-time PCR (Lee, Hoi et al. 2013). Primers used for qPCR are listed in Table 4.1.  
 
Chromatin immunoprecipitation (ChIP) and ChIP-seq library preparation 
For ChIP using keratinocytes, a previously described method was used (Lee, 
Hoi et al. 2013). 3-5 µg of H3 (Abcam), H3K4me3 (ActiveMotif), H3K9me3 
(Millipore or Abcam), H3K27me3 (Millipore), and IgG (Cell Signaling) were used for 
immunoprecipitation. For ChIP using FACS-isolated cells, 15-20 mice of CD1 x FVB 
wild-type strain was used. ~3-4 million bulge and non-bulge cells nuclei were isolated 
and treated with microccoccal nuclease (MNase) (50U, Affymetrix) to generate mono-
nucleosomal fragments. Isolated chromatin was processed further using described 
method (Lee, Hoi et al. 2013) for immunoprecipitation. Eluted ChIP DNA were either 
used for qPCR or further processed for sequencing library generation. ChIP-qPCR 
primers used are listed in Table 4.1. Library preparation was done using previously 
described method (Guertin and Lis 2010).  
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ChIP-seq data analysis 
Single-end sequencing was performed using Illumina GAIIx (Catagen Non-
bulge, 86nt) or HiSeq (Anagen bulge, 100nt). Initial analysis of ChIP-seq data were 
performed by the Computational Biology Service Unit (CBSU) of Cornell 
Bioinformatics Facility (Collaboration with Dr. Lishuang Shen). ChIP-seq reads were 
aligned using Bowtie (aligning tool) (Langmead, 2000) on mouse genome (mm9) and 
peaks were called using Model-Based Analysis of ChIPseq (MACS) (Zhang, Liu et al. 
2008). However, MACS-called peaks are narrow and the peaks may not be directly 
comparable across different samples quantitatively. To resolve this problem, in 
consultation with Dr. Qi Sun, we are currently devising a new quantitative analysis 
pipeline. First, peaks will be called for each histone mark in each sample using MACS. 
Second, we will combine all peak locations called from all samples analyzed and 
create an annotation file. Thirdly, we will use a more quantitative RNA-seq pipeline 
known as ‘Cuffdiff’ (Gao, Kim et al. 2010; Kvam, Liu et al. 2012), which measures 
the number of reads (quantitative measurement of differential expression) sitting on 
the specific genomic location defined above and normalized per number of reads 
sequenced. For instance, if on certain genomic location, one sample has a peak but 
another sample does not, the comparison may not be quantitative. Thus, by generating 
a concatenated annotation file for all peaks called in all samples analyzed, we can feed 
the annotation file into Cuffdiff and quantitatively measure the number of reads on all 
genomic locations.   
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Fluorescence Recovery After Photobleaching (FRAP) 
 Tails of K5-tTA x pTRE-H2BGFP (Tumbar, Guasch et al. 2004; Lee, Hoi et al. 
2013) mice were snipped, kept in PBS and brought to confocal microscopy 
immediately. Hair follicles at the edges of the tissue sample were imaged. A Zeiss 
confocal LSM 710, 30mW Argon/Neon laser at 80% power, 10 iterations was used to 
bleach 1/3-1/4 of the nucleus, including both heterochromatin and euchromatin. 
Images were collected at 1% power, every 10 seconds for 40 cycles, and processed 
with MetaMorph software. Data analysis and exponential curve fitting were performed 
by easyFRAP software (Rapsomaniki, Kotsantis et al. 2012). All statistical analyses 
were performed by two-sided student t-test. For FRAP recovery curves, a logarithmic 
trendline was fit for each curve of individual cells, and the slopes of the curves, 
representing how fast the recovery was, were subjected to the t-test.  
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Table 4.1. List of primers used for qPCR and ChIP-qPCR 
 
Application Gene/Region Forward Reverse 
qPCR Suv39h1 GCTCTGCCTCCTCTGAGGTAA TCTCTGCATCTTCCGCACTA 
qPCR Suv39h2 CTGCCCAGGATAGCATTGTTC CAAGTCTCGGCTCCACATTTAC 
qPCR Ezh2 AGTGACTTGGATTTTCCAGCAC TCACCATGCACTTTTCCATCAT 
qPCR Jarid1a TTTATCGGGCGCATCCGGCC TCATTGCCTCAAGTTCATTCAGGCG 
qPCR Jmjd2a GCGACCCTTGGTCTTCTTATT GGAGAGCCGAGTGTGAAGAA 
qPCR Utx CGGGCGGACAAAAGAAGAAC CATAGACTTGCATCAGATCCTCC 
qPCR Setdb1 TGCAGCGTTTGTTACACTCA CCAGCTAACTATCCAGGCCA 
qPCR Ehmt1 TGGCCACCACAAAGTCCCAGACA GCTTTCTCGCCCTTGGCGCC 
qPCR Cbx3 ACTGGACCGTCGTGTAGTGAA GCCCCTTGGTTTGTCAGCA 
qPCR Cbx5 GACAGGCGCATGGTTAAGG CCTGGGCTTATTGTTTTCACCC 
qPCR Ezh1 TCCAGTATGTGATGCATTTGG TGCGTCTCAGGATGGAGG 
qPCR Bmi1 TGATTCTGGTTGTTCGATGC TGGCTCGCATTCATTTTATG 
qPCR Jmjd3 TGAAGAACGTCAAGTCCATTGTG TCCCGCTGTACCTGACAGT 
qPCR Cbx6 CTCGGCTTGACAGAGAAATG AGGGAACGTGAGCTGTATGG 
qPCR Ash1l AAGTGCATGGTGTGGCAGCACTG CTGGGCATAGTGGGGCCTAGGG 
qPCR Jarid1b GAAGAGTTCGCGGACCCCTTCG GTGTTTGGGCCTCCAGCTCATTCAG 
qPCR Jarid1c CACTGTGGTAAGCACGAGGA CTCGTCACCCTCATGAATCC 
qPCR Keratin1 AACCCGGACCCAAAACTTAG CCGTGACTGGTCACTCTTCA 
qPCR Keratin5 CCTGCAGAAGGCCAAGCA TGGTGTTCATGAGCTCCTGGTA 
qPCR CD34 AAGGCTGGGTGAAGACCCTTA TGAATGGCCGTTTCTGGAAGT 
qPCR 
Oct4/Klf4 
(transgenic) TCTGTTCCCGTCACTGCTC AGAGAGTTCCTCACGCCAAC 
qPCR 
Sox2/Myc 
(transgenic) ACATGGGTAGTGGGCAATGT CGCAGATGAAATAGGGCTGT 
qPCR 
Oct4 
(endogenous) CAAGGCAAGGGAGGTAGACA CAAAATGATGAGTGACAGACAGG 
qPCR Klf4 ATGGTCAAGTTCCCAGCAAG TTTGTAAGTCCGGGCATGTT 
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(endogenous) 
qPCR 
Sox2 
(endogenous) AGTGGTACGTTAGGCGCTTC AAACCCAGCAAGAACCCTTT 
qPCR 
cMyc 
(endogenous) TTGAGGAAACGACGAGAACA GCCAAGGTTGTGAGGTTAGG 
qPCR 
Nanog 
(endogenous) TACCTCAGCCTCCAGCAGAT GATGCGTTCACCAGATAGCC 
qPCR 
Rex1 
(endogenous) CGGAGAGAAGCCGTATCAGT CTTTGCGTGGGTTAGGATGT 
qPCR 
Dppa5 
(endogenous) CAGTCGCTGGTGCTGAAATA GCCCGAATCTTGTTGTTTTG 
qPCR 
Fbx15 
(endogenous) GGCCTTGAATGGAGAACTGA GCACACTCCTCCTACGCTGT 
ChIP-qPCR CD34 TCTCTCTCCTCCTGCCTTGA AGCACTCCTTGTGCTTCTCC 
ChIP-qPCR Ltbp1 GCAGACAGTATCCGAGCAAA CGCCAGGAAAAGACAAAGG 
ChIP-qPCR Bmp4 GCTCCCTTCTCCATAACCTG ACTGCTGCCCAAACTGATG 
ChIP-qPCR Keratin1 CTCAGTATATAAGGGCACGGCACT GACTCATGATGCCTTAGAGAGAGGT 
ChIP-qPCR Keratin10 AGCAAAGCCTAGCACCTGTGA GCTGCTGGAGCTGTATAGAACAGAC 
ChIP-qPCR Major Satellite GACGACTTGAAAAATGACGAAATC CATATTCCAGGTCCTTCAGTGTGC 
ChIP-qPCR Minor Satellite CATGGAAAATGATAAAAACC CATCTAATATGTTCTACAGTGTGG 
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4.3 Results 
4.3.1 The status of H3 tri-methylation at K9, K27, and K4 in hair follicle stem cells 
is distinct and undergoes global erasure in quiescence 
To begin to characterize the global chromatin status of hair follicle stem cells, 
we analyzed the level of H3K4me3 (active), H3K9me3 (repressive, heterochromatic), 
and H3K27me3 (repressive) histone modification marks by immunofluorescent 
staining of skin sections. First, H3K9me3 labeling revealed interesting cellular and 
global patterns. As expected, the H3K9me3 mark was universally present in different 
hair follicle/epidermal compartments including inner root sheath (IRS), outer root 
sheath (ORS), Matrix, and basal layer during anagen (Figure 4.2A). The H3K9me3 
mark was dispersed throughout the nucleus with multiple distinct domains of 
heterochromatin. Strikingly, in the bulge, there were cells containing these 
heterochromatin domain-positive cells (foci+) and cells lacking these domains (foci-) 
(Figure 4.2B). Quantification of fluorescence intensities between these two cell types 
within the bulge, revealed a significant differences where foci- cells showed relatively 
lower signal than foci+ cells (Figure 4.2C). Moreover, western blotting of H3K9me3 
using FACS (Fluorescence Activated Cell Sorting) isolated bulge (CD34+/α6-
integrin+) and non-bulge (CD34-/α6-integrin+) cells indeed showed a significant 
differences in H3K9me3 levels (Figure 4.2D), suggesting that the bulge cells are 
globally more hypo-methylated than other hair follicle / epidermal compartments.  
Next, we examined how the global status of histone methylation of hair follicle 
stem cells may change during the hair cycle. Strikingly, catagen/telogen bulge cells 
displayed significantly decreased global H3K9me3 level relative to anagen bulge   
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Figure 4.2. Hair follicle stem cells have distinct state of H3K9me3, H3K27me3, and 
H3K4me3, which undergoes global erasure upon quiescence 
 
(A) H3K9me3 (green) staining of hair follicle in anagen. ORS: Outer Root Sheath; 
IRS: Inner Root Sheath. Notice bright heterochromatic positive (foci+) cells in yellow 
circles. Also note that the bulge contains two different localization patterns of 
heterochromatic 1) foci + and 2) foci -, which are enlarged in (B). (C) Quantification 
of fluorescence intensity of z-stack images of foci (+) and foci (-) cells (D) Western 
blot of H3K9me3 and total H3 of FACS-isolated bulge and non-bulge cells at anagen 
show clear differences in global H3K9me3 level (E) H3K9me3 localization pattern in 
anagen (PD24) and telogen (PD48). Note the clear qualitative differences in global 
level of H3K9me3 (F) Quantification of number of foci+ cells in the bulge across the 
hair cycle. (G) Western blot of H3K9me3 and total H3 of FACS-isolated bulge and 
non-bulge cells at anagen (PD27) and catagen (PD42) (H-I) Global localization pattern 
of H3K4me3 and H3K27me3 respectively during the hair cycle show similar behavior 
as H3K9me3.  
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(Figure 4.2E). Indeed, quantification of number of foci+ cells as well as western blot 
using FACS-isolated bulge (CD34+/α6-integrin+) and non-bulge cells (CD34-/α6-
integrin+) both revealed a significant reduction in global H3K9me3 levels as bulge 
cells enter quiescence (Figure 4.2E and F). Moreover, proliferating cells marked either 
by BrdU or Ki67 showed higher propensity of being foci+, suggesting that cells 
undergoing divisions gain H3K9me3, which then undergo significant erasure of this 
mark as these cells re-enter quiescence (Figure 4.3A-C). Notably, ~30% of bulge cells 
that are foci+ undergo proliferation, which is ~5-fold higher than foci- bulge cells 
(Figure 4.3D).  
Interestingly, similar changes took place for H3K4me3 (active) and 
H3K27me3 (repressive) marks, suggesting that the global status of bulge cells histone 
H3 tri-methylations at different N-terminal lysine residues may be up-regulated during 
self-renewal but undergo global erasure upon re-entrance into quiescence (Figure 4.2H 
and I). A notable thing to mention was that global levels of H3K4me3 and H3K27me3 
were also down-regulated to some extent in cells throughout the skin outside the bulge 
(Figure 4.2H and I). A previous study that employed a similar approach using mouse 
tail instead of dorsal skin did not document the quiescent versus proliferating follicle 
(Frye, Fisher et al. 2007). Collectively, these data suggest that hair follicle stem cells 
have overall low stats of both active (H3K4me3) and repressive (H3K9me3 
/H3K27me3) histone marks that is distinct from other compartments of hair follicle 
and epidermis, which is increased during proliferation but undergoes global erasure 
upon quiescence. Presence of both active (H3K4me3) and repressive (H3K27me3) 
marks on a specific promoter in embryonic stem cells was considered a special status   
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Figure 4.3. Gain of H3K9me3 mark correlates with proliferation of bulge cells.  
 
 
(A) Co-localization of H3K9me3, Ki67, and CD34 in early anagen shows that Ki67+ 
cells of the bulge gain H3K9me3 foci+ marks (B-C) Quantification of foci+ and foci- 
cells in CD34+/BrdU+ and CD34+/Ki67+ cells. Note that majority of dividing bulge 
cells are foci+ (D) Quantification of BrdU+ cells that are foci+ and foci- in CD34+ 
cells. Note the 5-fold increase in BrdU+ cells in foci+ relative to foci- cells. 
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of bivalency that allows cells flexibility in either turning on and off specific lineage 
genes. We speculate that in tissue stem cells, erasure of both of these two marks as 
well as of H3K9me3 and potentially other marks may provide cells a state of low 
epigenetic identity which may confine high plasticity that coincides with the stage in 
which stem cells decide to either self-renew or differentiate.  
 
 
4.3.2 Distinct genome-wide molecular changes upon hair follicle stem cells 
entrance to quiescence 
Given the massive histone H3 demethylation that we observed in bulge cells at 
catagen, it is possible that these changes occurred not only in genic regions, but also in 
intergenic regions, non-genic regions, and repeat regions. Given that only a finite 
number of genes change expression upon quiescence such widespread changes in 
methylation would explain the obvious massive differences we observed at the cellular 
level by immunostaining and western blots. Next, we characterized in more depth the 
genomic localization of histone H3 tri-methylation on K9, K27, and K4 during hair 
follicle stem cells proliferation, quiescence, and differentiation using chromatin 
immunoprecipitation (ChIP) followed by deep sequencing (ChIP-seq) (Park 2009; 
Furey 2012). Although recently published work from another laboratory described a 
similar approach, the study never analyzed the status of H3K9me3, uses a different 
stage of quiescence (telogen), and did not use a quantitative approach to determine the 
level differences between different hair cycle stages (Lien, Guo et al. 2011). In fact,  
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Figure 4.4. Control experiments to validate the ChIP protocol using FACS-isolated or 
in vitro grown keratinocytes. 
 
(A) ChIP-qPCR of FACS isolated bulge and non-bulge cells. CD34 and Ltbp1, which 
are expressed in the bulge show decrease in H3K27me3 in the bulge, but higher level 
in the non-bulge cells. On the other hand, Bmp4 and Keratin 1, which are expressed in 
non-bulge cells, display opposite pattern of H3K27me3. (B) Control ChIP-seq using in 
vitro keratinocytes show expected enrichments of different modification marks in 
specific regions.  
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conventional analysis of histone modification distribution at promoters previously 
published did not parallel the changes in gene expression observed at telogen and 
anagen by microarray data (Lien, Guo et al. 2011). Finally, our immunostaining data 
suggest that by telogen the level of histone marks is elevated again, making catagen 
the stage with the lowest potential epigenetic identity as suggested by low methylation 
of critical transcriptional regulatory H3 marks (K9, K27, and K4) and this stage was 
never probed before by ChIP-seq.  
Thus, we FACS-isolated bulge (CD34+/α6-integrin+) and non-bulge (CD34-
/α6-integrin+) cells from early anagen mouse skin when rapid self-renewal takes place 
with an increase in histone H3 tri-methylation marks (between PD22-25), and in 
catagen when the bulge cells are quiescent with globally low status of histone H3 tri-
methylations (between PD39-43). Also, we are collaborating with CBSU 
bioinformaticians to develop a more quantitative approach using different pipelines 
(see Materials and Methods).  
Due to the limitation in the number of sortable bulge cells per each mouse 
(~200,000 cells), we had to merge 15-20 mice per each stage to obtain enough cells 
for one experiment. Approximately 3-4 million sorted populations were split into five 
different ChIPs (H3, H3K4me3, H3K9me3, H3K27me3, and IgG). Experimental 
validation of H3K27me3 using FACS-isolated bulge and non-bulge cells by ChIP-
qPCR clearly showed enrichments in expected regions, suggesting that our protocol is 
working (Figure 4.4A). In addition, validation of antibodies was done using cultured 
keratinocytes, where excess of cells can be obtained (Figure 4.4B).  
 176 
 
Currently, we have sequenced DNA isolated by ChIp using antibodies against 
H3K4me3, H3K9me3, H3K27me3, and IgG from anagen bulge cells and catagen non-
bulge cells. While our data are preliminary, our sequencing results do show clear 
expected differences in methylation patterns between the two populations (Figure 4.5). 
For instance, CD34 and Lgr5, key bulge cell-specific markers, carry H3K4me3 in 
anagen bulge population, but carry H3K27me3 in catagen non-bulge, which fits with 
the mRNA expression patterns of these genes (Zhang, Cheong et al. 2009) (Figure 
4.5A). On the other hand, genes expressed in the Matrix (differentiated) cells either 
show reduced H3K9me3/H3K27me3 (Cux1) or increased H3K4me3 (Tnfrsf19) in the 
catagen non-bulge. In addition, Tbx4, a non-hair follicle lineage gene, contains 
H3K9me3 and H3K27me3 on its promoter and gene body, which fits with its null 
expression in both populations (Figure 4.5A). Moreover, preliminary categorization of 
presence and/or absence of three marks within the list of genes specifically expressed 
in the bulge, in non-bulge, or outside the hair follicle lineages, revealed dramatic 
differences in composition (Figure 4.5B-F). For instance, in anagen, while ~48% of 
bulge-specific genes contained single H3K4me3, only ~32% of non-bulge genes and 
~14% of non-hair follicle lineage genes contained single H3K4me3 (Figure 4.5B-D). 
In addition, in catagen non-bulge, while ~32% of bulge-specific genes carried single 
H3K4me3, this number increased up to ~47% in non-bulge-specific genes (Figure 
4.5E and F). Although due to limiting starting material we could not perform serial 
ChIP for different histone marks, it is interesting to speculate on the existence of 
bivalent promoters (co-existence of H3K4me3 and H3K27me3 first observed in 
embryonic stem cells)  (Bernstein, Mikkelsen et al. 2006; Mikkelsen, Ku et al. 2007),  
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Figure 4.5. Preliminary ChIP-seq data analyses reveal dramatic differences in 
different histone modifications in bulge and non-bulge cells. 
 
 
(A) Snapshots of MACS-called peaks on different genomic locations from anagen 
bulge and catagen non-bulge using genome browser. (B-D) Distribution of histone 
marks (based on their presence or absence) in bulge-specific (B) (N=~300 genes), 
non-bulge-specific (C) (N=~500 genes), and not expressed in either populations (D) 
(N=~5000 genes) of anagen bulge population. (F-G) Distribution of histone marks in 
bulge-specific (E) (N=~300 genes) and non-bulge-specific (F) (N=~500 genes) of 
catagen non-bulge population. (K4: H3K4me3; K9: H3K9me3; K27: H3K27me3; 
K4K9: H3K4me3/H3K9me3; K4K27: H3K4me3/H3K27me3; K9K27: 
H3K9me3/H3K27me3; K4K9K27: H3K4me3/H3K9me3/H3K27me3).   
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as suggested by their localization to the same promoters in the genome. Notably, this 
bivalency occurred in hair follicle cells often together with H3K9me3 (K4K9K27), 
and the proportions of what are dramatically different between different list of genes. 
It will be interesting in the future to elucidate if the presence and/or resolution of these 
bivalent domains may play regulatory roles during the hair follicle homeostasis 
(Figure 4.5B-F). Taken together, our preliminary analyses suggest that there seems to 
be correlation of active and/or repressive histone marks with gene expression patterns. 
These analyses are qualitative, as they are only based on the presence or absence of 
peaks in these marks relative to a general background level. Currently, more 
quantitative approach of calculating the differences in methylation levels across the 
genome is being developed using RNA-seq pipeline (see Materials and Methods for 
details). Using this approach, we expect to detect higher methylation levels across 
different genomic loci in proliferating bulge cells that are significantly reduced upon 
quiescence. In addition we expect to identify specific genomic loci of significant 
differences and further explore the biological meaning behind them. 
 
4.3.3 Growth factor-mediated signaling regulates the global status of histone H3 
tri-methylation at K9, K27, and K4 of hair follicle stem cells through direct 
transcriptional regulation of histone modifying enzymes 
Next, we asked how different histone modifying enzymes that are responsible 
for placing or removing methylation marks are expressed during the proliferation and 
quiescence of hair follicle stem cells. Significant differences were observed from 
quantitative real-time PCR analysis of the mRNA expression level of these enzymes in  
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Figure 4.6. Growth factor-mediated signaling regulates the level of histone H3 tri-
methylations of hair follicle stem cells through direct transcriptional regulation of 
histone modifying enzymes. 
 
 
(A) Quantitative real-time PCR of specific histone modifying enzymes in FACS-
isolated bulge and non-bulge cells from anagen and catagen. Note that the expressions 
of specific histone modifying enzymes differ and correlate with the global change in 
modification levels (B) Low magnification (10x) image of Noggin-soaked fluorescent 
beads-injected (red) catagen skin section, co-localized with H3K4me3 (green). Note 
the presence of red particles in dermal region in close proximity to the hair follicle. (C) 
H3K27me3 staining of PBS- or Noggin-injected hair follicle. Note the clear increase 
in global level of H3K27me3 upon Noggin injection. (D) Preliminary quantification of 
number of H3K4me3 positive cells per bulge in different Noggin treated skin sections. 
Note the clear increase in H3K4me3+ cells per bulge upon Noggin injection (E) 
Schematic of experimental strategy to address the effect of serum and Bmp4 in 
transcription of different histone modifying enzymes. (Carrier: solution used to 
dissolve Bmp4) (F-G) Quantitative real-time PCR of specific histone modifying 
enzymes in keratinocytes treated with serum-free (Carrier, grey bar) condition and 
serum-free + Bmp4 (black bar). Suv39h1, Suv39h2, and Jmjd2a are specific enzymes 
for H3K9me3, and Ezh2 and Utx are specific for H3K27me3. Note the decrease in 
methylases and increase in demethylases.   
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FACS-isolated bulge (CD34+/α6-integrin+) and non-bulge (CD34-/α6-integrin+) cells 
(Figure 4.6A). For instance, Suv39h1/h2, two histone modifying enzymes specific for 
placing H3K9me3 (Rea, Eisenhaber et al. 2000; Lehnertz, Ueda et al. 2003), were 
specifically down-regulated in catagen bulge (CD34+/α6-integrin+) relative to anagen 
bulge (CD34+/α6-integrin+) (Figure 4.6A). Similar pattern was seen for Ezh2, a 
subunit of Polycomb Repressive Complex and a specific methylase for H3K27me3 
(Margueron and Reinberg 2011). On the other hand, Jarid1a, a specific histone 
demethylase for H3K4me3, was up-regulated in catagen bulge relative to anagen 
bulge, correlating with the global erasure of H3K4me3 during quiescence (Figure 4.2). 
These data suggest that specific histone modifying enzymes are transcriptionally 
regulated during the hair cycle and their expression levels correlate with the global 
change in histone H3 methylation.  
The transcriptional regulation of histone modifying enzymes as well as the 
global patterns of demethylation suggested that there are diffusible factors in the skin 
that might be at work. There is now a diverse study done in multiple signaling 
pathways mediated by intrinsic and/or extrinsic factors that play differential and 
important roles (Lee and Tumbar 2012). For instance, Bmp signaling is at high level 
during quiescence in the surroundings of the hair follicle including hair germ, inner 
bulge layer, dermal papillae and mesenchyme, and in adipocytes. On the other hand, 
Wnt and FGF (Fibroblast Growth Factor) signaling are up-regulated during 
proliferation. Inhibition of Bmp signaling as well as induction of Wnt signaling can 
activate hair follicle and induce proliferation. We reasoned that one or more of these 
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growth factors signaling might play important roles in inducing and/or removing 
global tri-methylation marks on histone H3.   
To address this possibility, we used an inhibitor of BMP, Noggin, which we 
used to soak fluorescent beads and injected them into the back skin of catagen mice 
(Figure 4.6B) for five days (Plikus, Mayer et al. 2008; Greco, Chen et al. 2009; 
Oshimori and Fuchs 2012). We then sacrificed mice, and immunofluorescently labeled 
the skin sections for different histone H3 methylation marks. Strikingly, our 
preliminary results show that inhibition of Bmp signaling resulted in a significant 
increase in global methylation levels of H3K4me3 and H3K27me3 (Figure 4.6C and 
D), suggesting that Bmp signaling during quiescence inhibits (or erases) global 
methylation levels, thus maintaining the low epigenomic status of these histone 
modification marks.  
Finally, we used in vitro keratinocytes to determine the effect of growth factors 
in expression of histone modifying enzymes. Keratinocytes in vitro have extensive 
proliferative ability, and the medium contains multiple growth factors (Barrandon and 
Green 1987). Strikingly, when serum was removed from the culture, expressions of 
histone modifying enzymes assessed by qPCR were significantly changed (Figure 
4.6E). Preliminary results indicate that Suv39h1/h2 methylases were progressively 
down-regulated, while Jmjd2a, a K9-specific histone demethylase was progressively 
up-regulated over time (Figure 4.6F). In addition, Ezh2 was significantly down upon 
6hr post-serum free while Utx, a K27-specific demethylase, was up-regulated by 4hrs 
post-serum free condition (Figure 4.6G). Moreover, when Bmp4 was added to the 
serum-free condition, the differences were enhanced further (Figure 4.6F and G), 
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suggesting that the transcriptional regulation of these histone modifying enzymes can 
be an additive effect of multiple signaling molecules including the Bmp.  
Interestingly, some of these histone modifying enzymes carry conserved 
binding motifs for Smad4 (not shown), a co-transcription factors that works with other 
transcription factors upon Bmp signaling to regulate downstream gene expression. 
This observation suggested that the histone modifying enzymes we studied here might 
be directly regulated in their transcription by Bmp and other signaling pathways (Lee 
and Tumbar 2012). This hypothesis remains to be tested experimentally. Taken 
together, growth factors that promote or inhibit hair follicle stem cell quiescence 
regulate multiple histone modifying enzymes that are responsible for placing or 
removing specific genome-wide marks of histone H3 tri-methylations, potentially 
through direct transcriptional regulatory mechanisms. 
 
 
4.3.4 Low level of histone H3 tri-methylation at K9, K27, and K4 marks in 
quiescence correlates with higher hair follicle stem cell genome plasticity for 
reprogramming 
So far, we have shown that hair follicle stem cells at quiescence bear globally 
low tri-methylation of both active (H3K4me3) and repressive (H3K9me3/H3K27me3) 
histone H3 methylations, potentially regulated by direct transcriptional control 
mediated by multiple growth factors. Obvious questions would be the following: Why 
and how do these phenomena take place? What is the functional relevance? 
Interestingly, similar observations have been made in other systems. For instance, 
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embryonic stem cells epigenome contains distinct level of histone modification marks 
such as globally low H3K9me3 / H3K27me3, which are increased in more lineage 
restricted cell types (Hawkins, Hon et al. 2010). Also, chromatin of embryonic stem 
cells is more hyperdynamic than that of more lineage-restricted cell types observed by 
fluorescence recovery after photobleaching (Meshorer, Yellajoshula et al. 2006). In 
addition, quiescent B lymphocytes also contained globally low level of H3K9me3 and 
its associated proteins, which allowed these cells to be more efficiently reprogrammed 
upon nuclear transfer assays (Baxter, Sauer et al. 2004). Moreover, multiple histone 
modifying enzymes function in more efficient reprogramming of somatic cells into 
induced pluripotent cells (Onder, Kara et al. 2012) and H3K9me3 act as a barrier 
during reprogramming (Chen, Liu et al. 2013). Finally, hair follicle stem cells at 
quiescence choose their fate – either to migrate out and become differentiated 
progenitors or to stay in the bulge and later self-renew during anagen (Zhang, Cheong 
et al. 2009). Taken together, we hypothesized that the low level of histone H3 tri-
methylation at K9, K27, and K4 is indicative of a potential globally low epigenomic 
status at quiescence that allows hair follicle stem cell genome to be more dynamic and 
plastic, allowing these cells to choose their fate (Figure 4.7).  
To address this question, we took two different approaches. First, to ask 
whether the genome is generally more plastic at catagen, we induced reprogramming 
using the four core transcription factors (Takahashi and Yamanaka 2006) of both 
quiescent and proliferative bulge cells. The rationale here is that if the quiescent bulge 
cells have higher genome plasticity, the bulge cells would be more efficiently 
reprogrammed at catagen. Second, we used fluorescence recovery after  
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Figure 4.7. Model for epigenetic regulation of hair follicle stem cell quiescence and 
fate determination.  
 
During quiescence, histone modifying enzymes are transcriptionally regulated by one 
or more growth factor signaling, leading to a global erasure of active and repressive 
histone methylation marks. The globally low epigenetic status of histone H3 tri-
methylation in quiescent hair follicle stem cells puts the genome into a hyperdynamic 
state, which aids in fate choice. Prior to activation, some bulge cells can migrate out to 
hair germ where they are destined to differentiate (Fate 2), remaining bulge cells self-
renew during anagen (Fate 1) to make up for the loss. HME: Histone Modifying 
Enzymes; Bulge-specific gene: genes specifically expressed in the bulge; 
Differentiation gene: genes expressed outside of the bulge.  
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photobleaching (FRAP) to assess the plasticity of the chromatin in proliferative and 
quiescent bulge cells.  
First, to induce reprogramming, we crossed K14-rtTA doxycycline-inducible 
transgenic line with Col1a-tetO-Oct4-Klf4-Sox2-cMyc (pTRE-OKSM) transgenic line 
carrying inducible core reprogramming factors (Takahashi and Yamanaka 2006). We 
fed mice with doxycycline chow in anagen and catagen for 5 days and 9 days, 
sacrificed mice, and FACS-isolated bulge and non-bulge cells to analyze the 
expression of reprogramming factors (Figure 4.8A). Interestingly, while endogenous 
pluripotency factor Nanog was expressed by 9 days of induction in unsorted skin 
samples, none of the sorted populations expressed any of the endogenous 
reprogramming factors (data not shown). This may be due to the overall low 
reprogramming efficiency where only a small fraction of total cells are reprogrammed 
and they potentially lose CD34 expression at that time, and therefore cannot be sorted 
in the bulge fraction. Recent study suggests that only 5-10% of cells are permissive to 
reprogramming while 90-95% of cells are refractory (Polo, Anderssen et al. 2012). 
However, previous studies also showed that during the reprogramming process 
lineage-associated genes are down-regulated first and the identity of the originating 
cells is lost prior to expression of pluripotency markers (Stadtfeld, Maherali et al. 
2008). Indeed we observed a significant reduction of hair follicle lineage-associated 
genes such as CD34 and Keratin5 upon 5 days of induction in anagen bulge (Figure 
4.8B). However, same duration resulted in only ~20-30% of transgenes induction in 
catagen bulge, which was not sufficient to reduce CD34 and Keratin5 (Figure 4.8C). 
Strikingly, upon 9 day induction, while catagen bulge still expressed only ~30-40% of  
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Figure 4.8. Quiescent hair follicle stem cells are more hyperdynamic and are more 
readily reprogrammed. 
(A) Experimental scheme of inducing reprogramming factors in anagen and catagen 
(B) Quantitative real-time PCR of 5-day induced transgenic reprogramming factors 
(each primer sets are designed to detect two transgenes) expressed in anagen (PD27) 
and catagen (PD44) bulge. Note that catagen bulge only express ~20-30% of 
transgenic reprogramming factors (normalized) relative to anagen bulge. (C) 
Quantitative real-time PCR of 5-day induced anagen and catagen bulge. Note the 
down-regulation of lineage-associated genes in anagen bulge but not in catagen bulge 
by 5 days (D) Quantitative real-time PCR of 9-day induced transgenic reprogramming 
factors show ~30-40% induction in catagen bulge (normalized) relative to anagen 
bulge. (E) Quantitative real-time PCR show similar extent of down-regulation of 
lineage-associated genes in anagen and catagen bulge. (F-H) Chromatin dynamics of 
H2B-GFP protein in hair follicle of K5tTA x pTRE-H2BGFP mice (n=2) (F) 
Representative image of fluorescence recovery after photobleaching (FRAP) (G) 
FRAP curves (H) Estimated mobile fractions in each condition after exponential curve 
fitting. Note that the quiescent bulge cells have the highest mobile fraction. (I-K) 
Chromatin dynamics of H2B-GFP protein in K5rtTA x pTRE-H2BGFP keratinocytes 
in vitro (I) Representative image of fluorescence recovery after photobleaching 
(FRAP). Low Ca: proliferating cells; High Ca: differentiated cells; LSM (low serum 
media): quiescent cells (J) FRAP curves (K) Estimated mobile fractions in each 
condition after exponential curve fitting. Note the highest mobile fraction in cells 
cultured under low serum media. 
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transgenes relative to anagen bulge, there was a similar extent of down-regulation of 
CD34, Keratin1 and Keratin5 (Figures 4.8D and E). These preliminary data potentially 
suggest that even with a lower amount of transgene induction, catagen bulge are more 
readily reprogrammed than the anagen bulge.  
Secondly, using transgenic mice expressing H2B-GFP under repressible 
Keratin5 promoter (K5tTA x pTRE-H2BGFP) (Tumbar, Guasch et al. 2004), we 
employed fluorescence recovery after photobleaching (FRAP) to assess the dynamic 
nature of chromatin in quiescent and proliferative bulge cells as well as terminally 
differentiated cell types. Using whole tissue samples we photobleached H2B-GFP-
expressing bulge cells in anagen (proliferating), in catagen (quiescent), and Matrix or 
Inner Root Sheath cells (differentiated) (Figure 4.8F-H). Strikingly, quiescent bulge 
cells showed the fastest recovery kinetics. H2B-GFP exchange rates, as well as 
estimated mobile fractions, were significantly lower in proliferating cells (p<0.001), 
followed by differentiated cells (p<0.05) (Figure 4.8F-H). In addition, FRAP analysis 
of in vitro keratinocytes expressing H2B-GFP (K5rtTA x pTRE-H2BGFP) cells 
cultured under different conditions (low Calcium: proliferating; high Calcium: 
differentiated; low serum media: quiescent) showed striking similarity to the in vivo 
data (Figure 4.8I-K). The recovery kinetics was fastest in quiescent cells, with the 
recovery rate of up to 22% of initial intensity (Figure 4.8I and J). Actively dividing 
cells recovered 15% (p<0.05) while differentiated cells recovered less than 10% 
(p<0.0001). One important control that we will add to these data is estimating the total 
amount of H2B-GFP in the different cell types we analyzed here. However, it is 
unlikely that especially in cell culture the rapid manipulation of conditions tested on 
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the same cell line may induce any detectable differences in overall H2B-GFP level. In 
addition, the rate of recovery is not dependent on the total amount of the protein but 
rather on the speed with which the protein move around. Our measurements here are 
not limited by normal diffusion, which has been measured on the order of seconds, 
while the recovery measured here is on the order of minutes. Additional studies will be 
required to consolidate these data. Taken together, these data may suggest that the 
quiescent bulge cells have higher genome plasticity as indicated by more productive 
early steps of reprogramming at this stage, and potentially a more dynamic chromatin 
with faster exchange rates of a core histone-histone H2B. We speculate that the high 
genome plasticity during quiescence potentially may contribute to bulge stem cells 
fate decision prior to activation.  
 
 
4.4 Preliminary Conclusions 
Here we use hair follicle as a model to decipher how the global status of 
important histone methylation marks of hair follicle stem cells is regulated. Although 
preliminary, our data suggest potential functional significance of this regulation during 
hair follicle homeostatic balance between proliferation, quiescence, and fate decision. 
Hair follicle stem cells appear to have a distinct epigenome characterized in part by 
globally low levels of both active (H3K4me3) and repressive (H3K9me3/H3K27me3) 
histone H3 marks relative to other hair follicle compartments (Figure 4.2). This status 
seems to be maintained by multiple growth factors signaling present around the hair 
follicle environment, which mediate direct transcription of responsible histone 
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modifying enzymes (Figure 4.6). Interestingly, the state of hair follicle stem cells 
quiescence correlates with a seemingly more dynamic chromatin and a more plastic 
state of their genome (Figure 4.8). Because this state coincides with the stage of hair 
follicle stem cells fate decision, it is tempting to speculate that it may enable the fate 
choice of quiescent hair follicle stem cells to decide either to migrate out from the 
niche and differentiate, or to remain in the niche and self-renew later to make up for 
the loss (Zhang, Cheong et al. 2009). Here we unveil a novel regulatory model through 
which growth factor mediated global histone H3 tri-methylation status at K9, K27, and 
K4 may couples the known state of tissue stem cell quiescence with that of low 
epigenetic identity or high plasticity, which is a hallmark of stem cell. Further work 
will be necessary to directly test several aspects of this model in vivo, and understand 
how widespread the erasure of histone marks, and potentially other components of the 
epigenome, is at tissue stem cell quiescence.   
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CHAPTER 5  
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
 
 
 
5.1 Cell cycle control of hair follicle stem cell quiescence 
Tissue stem cells are capable of proper maintenance of the tissue they reside in 
(Fuchs 2009). In order to do so, tissue stem cells adopt mechanisms to not only 
maintain their clones but also to produce enough progenitors that would differentiate 
and form the tissue structure. Therefore, even subtle changes in the cycling property of 
tissue stem cells could potentially be a threat to proper tissue homeostasis. 
To begin to understand the cell cycle regulation during hair follicle cycling, we 
characterized how CDKis are expressed and regulated during the hair follicle 
homeostasis (Chapter 02). First, we found that multiple CDKis were differentially 
expressed (Figure 3.1). P15, p21, and p57 were up-regulated in the bulge during 
quiescence. In addition, p57 and p27 were always highly expressed in the bulge, 
presumably to maintain the overall low number of bulge cell divisions. The protein 
expression pattern of Runx1 inversely correlates with the CDKis expressions. Runx1 
directly binds to the promoter of p21 and repress its transcription, and may potentially 
regulate p27 and p57 transcription as well.  
To further dissect the role of CDKis, we coupled the previously developed cell 
division tracking system using pulse-chase of tet-repressible H2B-GFP protein 
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(Tumbar, Guasch et al. 2004; Waghmare, Bansal et al. 2008; Zhang, Cheong et al. 
2009; Zhang, White et al. 2010), together with genetic ablation of p21. Interestingly, 
p21 knockout bulge cells failed to enter quiescence in catagen when wild-type bulge 
cells normally do (Figure 3.3 - 3.6). Instead p21 knockout bulge cells underwent 1-2 
more rounds of divisions before entering quiescence. Extra bulge cells generated did 
not result in an increase in stem cell pool, but rather die more by apoptosis.  
The significance of interaction between Runx1 and p21 was context-
dependent. In keratinocytes, p21 deletion was sufficient to rescue the growth defect of 
Runx1 knockout (Hoi, Lee et al. 2010). However, in tumorigenic condition, p21 KO 
only partially rescued the defect in tumor formation of Runx1 knockout (Figure 3.7). 
More strikingly, in vivo, absence of both p21 and Runx1 resulted in further extension 
of the delayed activation. Intriguingly, double knockout of Runx1 and p21 in vivo and 
in vitro up-regulated p15 expression (Figure 3.9). Interestingly, we found that both 
Runx1 and p21 proteins directly bind to p15 promoter on their respective binding 
motifs, and co-work to repress p15 mRNA expression.  
Together, these findings highlight several important perspectives of hair 
follicle biology as well as stem cell regulation in general. First, hair follicle stem cell 
quiescence is tightly regulated by multiple CDKis. During quiescence, p15, p21, p27, 
and p57 are up-regulated or maintained at high levels in the bulge. Considering the 
recent studies suggesting that one of the CDKis can compensate for the loss of another 
CDKi (Matsumoto, Takeishi et al. 2011; Tesio and Trumpp 2011; Zou, Yoshihara et 
al. 2011), it is plausible that multiple CDKis expressed in the bulge during quiescence 
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function redundantly. Our finding that p15 is up-regulated upon deletion of Runx1 and 
p21, also supports this possibility.  
Secondly, p21 regulates the timely exit from the cell cycle during the normal 
hair follicle homeostasis. Using H2B-GFP division tracking system together with 
mathematical and computational modeling, we were able to map and predict the 
behavior of bulge cells division. On the contrary to a conventional idea of CDKis 
regulating the self-renewal rates, p21 regulates the extent of division of hair follicle 
bulge cells. Overall, the bulge cells undergo on average one extra round of division 
before arrest in catagen. Notably, knockout of p21 homolog (Dacapo) in Drosophila 
also results in one extra round of cell division before arrest (de Nooij, Letendre et al. 
1996).  
Third, Runx1, a key transcription factor of multiple stem cell systems (Speck 
and Gilliland 2002), directly regulate p21 transcription and potentially other CDKis 
(p27 and p57) as well. This suggests that out of many downstream targets that Runx1 
acts on (Wilson, Foster et al. 2010), its action on CDKis expressions is an important 
axes of regulation that balance between stem cell proliferation and quiescence.  
Fourth, we uncovered a novel role of p21 that is independent of its kinase 
inhibition function, in regulating p15 transcription. P21 together with Runx1 were 
bound to the p15 promoter to synergistically repress p15 mRNA expression. While 
recent studies suggested that two CDKis (p21 and p27) play cell-cycle independent, 
transcriptional repressive roles (Devgan, Mammucari et al. 2005; Pippa, Espinosa et 
al. 2011; Ferrandiz, Caraballo et al. 2012; Marques-Torrejon, Porlan et al. 2012), it 
was not previously known that one CDKi can directly regulate on the promoter of 
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another CDKis. This suggests that a robust mechanism might be at work to maintain 
stem cell quiescence while keeping the level of CDKis in stem cells in check. The 
latter might be crucial for rapid activation of stem cells in response to injury or 
specific tissue homeostatic signals. These ideas remain to be tested experimentally in 
the future.  
Lastly, we unveil a robust multi-layered regulation of hair follicle stem cell 
quiescence. While Runx1 single knockout resulted in up-regulation of p21, p27, and 
p57, the levels of p27 and p57 appeared normal when p21 was knocked out in addition 
to Runx1. Given that p21 can bind to the p15 promoter and repress it, we can 
speculate that other CDKis may also work as CDKi transcriptional repressors. For 
instance, since double knockout t of Runx1 and p21 results in p15 up-regulation, p15 
may now repress p27 and p57, explaining why the last two CDKis were not up-
regulated in the Runx1/p21 double knockout. However, under Runx1 single knockout, 
p21 can maintain the repression of p15, which further allows p27 and p57 to be up-
regulated. This idea, which we refer to as ‘transcriptional circuitry of CDKis’, needs 
further exploration, but offer a potential mechanisms to explain the robustness and 
multi-layered cell-cycle regulation in tissue stem cells to balance between proliferation 
and quiescence.  
 
 
5.2 Regulation of hair follicle stem cell quiescence and genome plasticity 
via histone modifications 
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Epigenetics consists of broad range of regulatory mechanisms that are not 
governed by DNA sequence – DNA methylations, histone modifications, and other 
protein modifications (Kouzarides 2007). Of those, chromatin regulation is achieved 
through different histone modifying enzymes acting on different histone residues to 
place or remove chemical modifications that directly affect nearby transcription and/or 
openness of chromatin structure (Jenuwein and Allis 2001; Kouzarides 2007). Over 
the past decade, chromatin regulation of stem cells was shown to be a crucial 
mechanism that governs self-renewal and differentiation processes. However, if and 
how epigenetic mechanisms regulate hair follicle stem cells dynamic behavior of 
proliferation, quiescence, and differentiation, as well as how these regulation is 
achieved require further exploration. 
To begin to understand the epigenetic regulatory mechanisms underlying the 
hair follicle homeostasis, we characterized global localization patterns of three histone 
H3 tri-methlation marks (Chapter 03). We discovered very interesting phenomena 
during this process. First, hair follicle stem cells possess globally lower levels of 
H3K4me3, H3K9me3, and H3K27me3 than other compartments of the hair follicle 
(Figure 4.2). Unexpectedly, while globally low, proliferating hair follicle bulge cells 
gained these modification marks to some extent, which was followed by a global 
reduction (erasure) upon quiescence (Figure 4.2). In addition, progress in genome-
wide mapping using ChIP-seq is beginning to shed light on how hair follicle stem cells 
coordinate different marks of histone H3 tri-methylations in setting the state of 
proliferation, quiescence, and differentiation (Figure 4.5). Specific histone modifying 
enzymes for each mark such as Suv39h1, Suv39h2, Ezh2, and Jarid1a were 
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differentially expressed in the bulge at proliferation and quiescence. Interestingly, 
growth factor signaling including BMP signaling greatly influences the transcription 
of multiple histone modifying enzymes (Figure 4.6). We found that growth factors 
largely present during proliferative stage may bring increased levels of 
H3K4me3/H3K9me3/H3K27me3, whereas the absence of growth factors as well as 
the presence of inhibitory signaling such as BMP, leads to their reduction (erasure). 
Finally, we uncovered that this presumed low epigenomic status at quiescence 
potentially coincides with a more hyperdynamic chromatin state, which may 
potentially allow the more efficient reprogramming we have uncovered at this stage 
(Figure 4.8).  
Our findings open up a new interesting perspective into understanding tissue 
stem cell biology and epigenetic regulations. First, growth factor-mediated signaling 
drives histone methylation changes. Although many studies revealed the existence and 
function of different histone modifying enzymes play specific roles in placement or 
removal of certain modification residues (Kouzarides 2007), relatively less was known 
about what drives the expression of these enzymes themselves. Multiple growth 
factors signaling such as Wnt and FGF are highly present around the stem cells during 
the growth phase of the hair follicle (Lee and Tumbar 2012). On the other hand, BMP 
signaling takes over during the quiescent phases of the hair cycle and is present in 
dermis, dermal papillae, inner bulge layer, and hair germ (Lee and Tumbar 2012). 
Interestingly, recent study revealed that BMP-signaling induces histone demethylases 
that removes repressive histone marks, leading to mesenchymal stem cell 
differentiation (Ye, Fan et al. 2012). This finding, together with our work, suggest that 
 204 
 
downstream effectors of multiple growth factor signaling that are either intrinsic or 
surrounding the stem cells, may directly regulate the transcription of histone 
modifying enzymes. Intriguingly, histone modifying enzymes that were differentially 
expressed in the bulge at proliferation and quiescence such as Suv39h1, Ezh2 and Utx 
carry specific putative binding motifs for Smad4, a downstream effector of BMP 
signaling, which supports the notion that growth factor signaling may control the 
transcription of histone modifying enzymes.  
Secondly, the status of histone H3 tri-methylation at K4, K9, and K27 changes 
in the transition between hair follicle stem cells proliferation and quiescence. During 
anagen, majority of bulge cells that were undergoing division gained H3K9me3 mark. 
More strikingly, Noggin induction in catagen to inhibit BMP signaling resulted in 
increased H3K4me3 and H3K27me3 marks without induction of proliferation. These 
findings suggest that histone methylation changes may occur prior to entering 
proliferation. This is consistent with previous studies showing that histone modifying 
enzymes action on cell cycle regulators affect the self-renewal ability of tissue stem 
cells (Fasano, Dimos et al. 2007; Ezhkova, Pasolli et al. 2009; Velichutina, 
Shaknovich et al. 2010; Ezhkova, Lien et al. 2011). In Chapter 2, we also showed that 
the p21 promoter shows increased enrichment of H3K27me3 upon Runx1 binding 
likely through recruitment of Polycomb Repressive Complex (Yu, Mazor et al. 2012). 
Also, recent studies in the cancer field showed that some of these histone modifying 
enzymes, and especially Ezh2, function to control cell cycle regulators in preventing 
metastasis (Jacobs, Kieboom et al. 1999; Molofsky, Slutsky et al. 2006; Bracken, 
Kleine-Kohlbrecher et al. 2007; Richter, Plehm et al. 2009; Velichutina, Shaknovich et 
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al. 2010). These studies suggest a hypothesis in which during quiescence, the removal 
of histone repressive marks on promoters such as p15, p21, and p27 results in up-
regulation of their mRNAs, followed by cell cycle arrest at catagen. The quantitative 
analyses on more ChIP-seq data (presented in Chapter 4) will reveal this aspect. Taken 
together, these findings together suggest that epigenomic status arranged by histone 
modifying enzymes may be important in balancing between the proliferation and 
quiescence of stem cells.  
Finally, recent studies in embryonic stem cells (Meshorer, Yellajoshula et al. 
2006, Hawkins, Hon et al. 2010, Luger, Dechassa et al. 2012, Onder, Kara et al. 2012; 
Chen, Liu et al. 2013) as well as in more lineage restricted cell types (Baxter, Sauer et 
al. 2004) suggest that epigenomic status (as narrowly defined here by histone 
modifications) is known to influences stem cell genome plasticity. Our findings in the 
hair follicle stem cells seem to be consistent with these studies. Perhaps quiescent 
bulge cells with globally low epigenomic status in catagen may allow the chromatin to 
be more hyperdynamic under fluorescence recovery after photobleaching, be more 
plastic and readily reprogrammed. Most importantly, the genome plasticity during 
quiescence is likely to aid in fate decision of bulge cells prior to activation (Zhang, 
Cheong et al. 2009). 
 
 
5.3 Perspective: unveiling the robustness of stem cell quiescence during 
hair follicle homeostasis 
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As discussed so far, tissue stem cells dynamic behavior during homeostasis is 
regulated by complex mechanisms and we are nowhere near the complete 
understanding of their biological implications. The two very different findings of this 
study – 1) the robust regulation of hair follicle stem cell quiescence through 
transcriptional control of cell cycle regulators, and 2) the correlation between growth 
factor-mediated low epigenetic status during hair follicle stem cell quiescence and 
high genome plasticity – give us some new insights.  
Hair follicle stem cells in their niche remain relatively quiescent. Surrounding 
the niche, multiple growth factors that are activating and inhibitory signaling (Wnt, 
FGFs, BMPs and etc) from dermis, hair germ, dermal papilla, inner bulge layer, 
adipocytes, send signals to the niche to achieve the quiescence. These signals (such as 
BMP) can lead to activation/repression of histone modifying enzymes, which can lead 
to global change in epigenome. Often these histone modifying enzymes (such as Bmi1, 
Ezh2, Suv39h1) may co-work with intrinsic transcription factors (Runx1 and Nfatc1) 
to control the expressions of cell cycle regulators (p21 and p16) that are critical for 
proliferation. Hair follicle bulge cells have overall high level of multiple CDKis and 
even among these a complex transcriptional regulatory network may be at work to 
ensure that the proper level of CDKis are functioning to maintain quiescence.  
Meanwhile, the globally low epigenomic status maintained by inhibitory 
growth factor signaling may bring the quiescent bulge cells chromatin to a more 
hyperdynamic and opened state. This may allow quiescent bulge cells to choose either 
to migrate out from the niche and acquire progenitor cell fate, or remain in the niche 
and participate in replenishing the stem cell pool. Importantly, our study couples the 
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quiescence, which is a common feature of multiple tissue stem cells such as hair 
follicle and blood, to high genome plasticity manifested by low epigenomic status. 
This connection, although has been implicated in progenitor cell types such as 
quiescent B lymphocytes (Baxter, Sauer et al. 2004), has not previously been 
described in tissue stem cells. Taken together, hair follicle stem cell quiescence 
appears to be robustly controlled by cell cycle regulators, and surrounding growth 
factors mediate genome-wide chromatin changes that may predispose the genome into 
an open chromatin state for assisting fate determination. 
 
 
5.4 Future directions 
While all contents of Chapter 3 have been published, data shown in Chapter 4 
is preliminary. To strengthen our preliminary findings and make firm conclusions, 
further experiments must be pursued. Here I describe experimental details. First, I will 
perform ChIP-seq of missing populations – catagen bulge and anagen non-bulge – for 
H3K4me3, H3K9me3, and H3K27me3. IgG ChIP will be used as a control. Library 
preparation will be performed as (Guertin and Lis 2010). Sequencing will be done 
using single-end Illumina HiSeq available through Cornell Life Sciences Core 
Laboratories Center. Also, biological replicates will be necessary for all populations. 
All sequencing data will be analyzed as discussed in Materials and Methods section of 
Chapter 4. In addition, I will correlate the changes in histone H3 tri-methylation 
landscape with gene expression profiles previously obtained in our laboratory to assess 
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how these specific changes in histone H3 tri-methylations may influence gene 
expressions makeup of the self-renewing and quiescent bulge stem cells, as well as the 
makeup of the non-bulge cells. These analyses will bring quantitative insights into 
how genome-wide molecular epigenetic changes occur during the process of hair 
follicle stem cells proliferation, quiescence, and differentiation, and determine the role 
of these changes in cellular identities.  
Second, I will address which growth factors are important for mediating the 
transcription of histone modifying enzymes in vitro. As shown in Figure 4.6, serum 
removal results in down-regulation of multiple histone modifying enzymes. Serum 
contains several growth factors that promote proliferation of keratinocytes. By using 
chemical inhibitors that inhibit specific growth factors or their binding receptors, I will 
be able to narrow down the list. Conversely, under serum-free condition, I can add 
recombinant growth factors that are important for in vivo activation of bulge cells such 
as FGF7, TGF-β2, Noggin, and Wnt molecules (Lee and Tumbar 2012) and analyze 
whether the expression of histone modifying enzymes will be reversed. After 
determination of specific growth factor(s) signaling, I will analyze the direct 
transcriptional regulation by chromatin immunoprecipitation followed by quantitative 
real-time PCR (ChIP-qPCR), to identify whether the downstream effector of the 
specific signaling binds to the promoter of different histone modifying enzymes. For 
instance, Suv39h1, Ezh2, Utx, and Jarid1a contain putative binding motifs for Smad4, 
a downstream effector of BMP signaling. In addition, to determine whether change in 
the expression of histone modifying enzymes indeed cause global change in the level 
of histone H3 tri-methylations, I will collect keratinocytes treated with normal serum, 
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serum-free, serum-free+Bmp4, and other chemical inhibitors or recombinant growth 
factors for histone protein extraction followed by western blotting of H3K4me3, 
H3K9me3, and H3K27me3. Taken together, these experiments will establish which 
growth factor(s) mediate the global changes is histone H3 methylation status by direct 
transcriptional regulation of specific histone modifying enzymes.  
Third, I will further examine the functional relevance of quiescence, global low 
epigenomic status, and genome plasticity. Using inducible transgenic mice expressing 
core reprogramming factors (K14-rtTA x Col1a1-tetO-Oct4-Klf4-Sox2-Myc), I showed 
that even after 9 days of doxycycline treatment, neither the proliferating nor quiescent 
bulge cells expressed reprogramming / pluripotency markers (data not shown). This 
may be due to 1) insufficient duration of doxycycline treatment or 2) low efficiency of 
reprogrammed cells. Fibroblasts undergoing reprogramming pass through intermediate 
stages where they down-regulate lineage associated genes before expressing 
pluripotency markers suggesting that our bulge cells at 9 days doxycycline induction 
may be at an intermediate stage (Stadtfeld, Maherali et al. 2008; Polo, Anderssen et al. 
2012). On the other hand, considering that reprogramming only occurs in 5-10% of 
cells exposed to reprogramming factors (Polo, Anderssen et al. 2012), it may not be 
feasible to clearly distinguish the differences even under longer doxycycline treatment. 
Thus, I will also take an alternative approach by immunohistochemistry of 
pluripotency markers such as alkaline phosphatase, SSEA-1, and Nanog. By 
examining the difference in relative abundance or presence of these markers will allow 
us to conclude whether the quiescent bulge cells indeed have higher genome plasticity. 
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Fourth, recent advances in assessing the kinetics of protein dynamics suggest 
that more thorough analyses of our FRAP data may be needed (Mueller, Mazza et al. 
2010; Stasevich, Mueller et al. 2010; Mueller, Morisaki et al. 2012). First, discussions 
with Dr. Tom Misteli and Dr. Warren Zipfel, clearly suggested that simple diffusion of 
macromolecules including H2B-GFP takes place in the order of seconds. This 
indicates that the difference in the amount of recovery that takes place over the 
minutes (Figures 4.8G and 4.8J) is not likely due to the simple diffusion. However, the 
differences in the mobile fraction  that we detect in both in in vivo and in vitro (Figure 
4.8H and 4.8K) may be due to the differences in the total amount of H2B-GFP present 
in different cell types. In order to rule this out, I will perform a western blot of H2B-
GFP extracted from keratinocytes at proliferative, quiescent, and differentiation 
conditions in vitro. Secondly, although many studies have shown similar results as 
ours (where the majority of the protein seems to be tightly associated to the chromatin 
with only a small diffusible component (Mueller, Karpova et al. 2012), different 
kinetic modeling can give varying outcomes of the dynamic state of the protein 
(Mueller, Karpova et al. 2012). In order to more quantitatively measure the kinetics, I 
will re-analyze the FRAP images (all cells and conditions represented in Figure 4.8I) 
using a different approach suggested by Dr. Warren Zipfel. I will take quantitative 
measurements of continuous strips of a few pixels covering the unbleached and 
bleached area. Just after the bleach, the edge of the unbleached and bleached area can 
be represented by a discontinuous function. However, as mobile fraction fills in the 
bleached area, the edge will bear sigmoid shape that can be represented by an error 
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function. Using this approach, I will be able to calculate more quantitatively the 
differences in how fast the H2B-GFP molecules migrate.  
Lastly, although it is beyond the scope of this graduate work, to firmly 
establish the significance of epigenetic regulation of hair follicle stem cells quiescence 
and genome plasticity, genetic manipulation of histone modifying enzymes can be 
achieved. For instance, using a transgenic line expressing histone modifying enzyme(s) 
to over-express one or more specific methylases during quiescence will reveal how 
global epigenomic status influence the proliferative status as well as the genome 
plasticity. Conversely, similar approach can be used by ablation of specific 
demethylases during quiescence. Moreover, although our work only characterized a 
few of these, there are other histone modifications that specifically mark different 
genomic loci. Therefore, in the future, it will also be interesting to analyze the role of 
other histone marks such as acetylation or methylation (in other lysine residues) in hair 
follicle stem cells self-renewal and fate determination. In addition, considering that 
placement, maintenance, and removal of different histone modification marks involve 
other histone-associated proteins as well as chromatin remodeling complexes, it will 
also be interesting to determine how individual components play a role in a concerted 
action of epigenetic regulation in governing stem cells self-renewal and differentiation. 
Also, as multiple epithelial cancers such as squamous cell carcinoma are influenced by 
mis-regulation of hair follicle bulge cells self-renewal and differentiation, it will be of 
great importance to dissect how epigenetic factors contribute to tumorigenesis. Overall, 
the future directions documented here will significantly strengthen our model of how 
epigenomic state of hair follicle stem cells is regulated during quiescence and the 
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biological meaning of this mechanism in proper cell fate choice. The discoveries made 
here will potentially be applicable to other tissue stem cell systems and serve as a basis 
of understanding the molecular pathway of diseases such as cancer. 
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